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ABSTRACT
Autism has been declared an urgent public health concern by the U.S. government and an
epidemic by some advocacy groups. Determining autism’s diagnostic criteria, prevalence, and
causes have been challenging. It is important to examine how the U.S. media have contributed to
the public’s understanding of autism. Previous research found that British media coverage of the
theory that vaccines cause autism was shown to contribute to the decline of vaccination rates in
Britain (Lewis & Speers, 2003). This study examined U.S. television news media coverage using
an agenda-setting theory and media framing perspective. A content analysis was conducted of
national television evening news broadcasts airing on ABC, CBS, and NBC from 1994, when
autism was first recognized as a spectrum disorder through April 2010, the time of this study.
Specifically, this study examined the saliency of autism stories and how autism was framed in
terms of prevalence and causes.

INDEX WORDS:

Autism, Vaccines, Television evening news, ABC, CBS, NBC, Agenda
setting, Framing, Content analysis

FRAMING AUTISM CAUSES AND PREVALENCE:
A CONTENT ANALYSIS OF TELEVISION EVENING NEWS COVERAGE—
1994 THROUGH APRIL 2010

by
ANGELA S. COLSON

A Thesis Submitted in Partial Fulfillment of Requirements for the Degree of
Master of Arts
in the College of Arts and Sciences
Georgia State University
2010

Copyright by
Angela Suzanne Colson
2010

FRAMING AUTISM CAUSES AND PREVALENCE:
A CONTENT ANALYSIS OF TELEVISION EVENING NEWS COVERAGE—
1994 THROUGH APRIL 2010

By

ANGELA S. COLSON

Committee Chair: Dr. Holley Wilkin
Committee: Dr. Cynthia Hoffner
Dr. Svetlana Kulikova

Electronic Version Approved:
Office of Graduate Studies
College of Arts and Sciences
Georgia State University
August 2010

iv
ACKNOWLEDGEMENTS
I would like to offer a special note of thanks to my thesis advisor, Dr. Holley Wilkin.
Words cannot express how grateful I am for her patience, persistence, and encouraging words
throughout this process. I would also like to thank Dr. Cynthia Hoffner for her interest in my
topic as well as her thorough review and thoughtful comments. Thanks to Dr. Svetlana Kulikova
for helping me understand the best method for answering my research questions in her course.
I’m grateful to all of you for serving on my committee. Many thanks to Dr. Mary Stuckey for her
guidance.

v
TABLE OF CONTENTS
ACKNOWLEDGEMENTS

iv

LIST OF TABLES

vii

LIST OF FIGURES

viii

CHAPTER
1. INTRODUCTION AND BACKGROUND

1

Early Autism Accounts

5

Labeling and Describing Autism

7

Autism: A Distinct Disorder

11

Autism Prevalence and Rates

15

Autism Causes and Risk Factors

22

2 . THEORETICAL FRAMEWORK: AGENDA SETTING AND FRAMING

29

Agenda-Setting

29

Framing and Second-Level Agenda Setting

32

Mass Media Coverage of Autism

35

Research Questions

39

3. METHODS

44

Selection of Broadcast Transcripts

44

Coding Procedure

46

Reliability

51

Data Analysis

52

4. RESULTS
Prominence of Autism-related Stories

53
53

vi
Autism Causes and Risk Factors

56

Autism Prevalence and Rates

60

Sources

63

5. DISCUSSION

70

Prominence of Autism-related Stories

70

Autism Causes and Risk Factors

74

Autism Prevalence and Rates

76

Sources

78

Limitations of the Study

80

Suggestions for Future Research

81

Conclusion

82

REFERENCES

84

APPENDIXES
A: CONTENT ANALYSIS CODE BOOK

90

B: CONTENT ANALYSIS CODE SHEET

107

vii
LIST OF TABLES
Table 3.1.

Intercoder Reliability: Variables and Corresponding kappa values

51

Table 4.1.

Frequency of autism-related story by placement in broadcast.

56

Table 4.2.

Frequency that specific causes were identified within stories that identified
potential causes of autism.

59

Table 4.3

Frequency that when a cause is included in a story, it is presented as a
likely cause, an unlikely cause, or that more information is needed to
determine if it is a cause of autism.

60

viii
LIST OF FIGURES
Figure 4.1.

Frequency of autism-related stories by year.

55

Figure 4.2.

Frequency of autism stories mentioning or focusing on vaccines by
year.

55

Figure 4.3

Frequency that stories framed vaccines as a likely, unlikely or that not
enough is known to determine it as a cause of autism by year.

61

Figure 4.4

Frequency of prevalence, rates of autism included in autism-related
stories, per year.

63

Figure 4.5

Frequency of stories characterizing autism as increasing by year.

63

Figure 4.6

Frequency of stories characterizing autism as an epidemic by year.

64

Figure 4.7

Frequency of individuals interviewed in all autism-related stories.

69

Figure 4.8

Frequency of individuals interviewed about causes.

70

Figure 4.9

Frequency of individuals interviewed about vaccines.

71

1
CHAPTER 1
INTRODUCTION AND BACKGROUND
Throughout the evolving understanding of autism, it seems the disorder has always held a
fascination for the public and those who have researched it. Autism or autism spectrum disorders
(ASDs), as many in the scientific community now describe it, are a “group of developmental
disabilities characterized by atypical development in socialization, communication, and behavior.
ASDs typically are apparent before age 3 years, with associated impairments affecting multiple
areas of a person's life” (Centers for Disease Control and Prevention, 2009a, np). It has been said
that very little about autism is ever noncontroversial (Donnellan, 1985) and it is not surprising
that many advocacy groups have adopted a puzzle as the symbol for autism given that
determining the diagnosis criteria, the prevalence, as well as causes and risk factors have proven
to be challenging. Determining the diagnostic criteria has especially been difficult. In fact, the
recognition of autism as a spectrum disorder did not occur until 1994 when the American
Psychiatric Association included Asperger syndrome and other developmental disorders in the
fourth edition of its Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), the
standard by which mental disorders are diagnosed in the United States.
The lack of established diagnostic criteria for autism or ASDs has meant inconsistent
diagnoses and affected how and whether children received services. For many years, researchers
believed the prevalence of autism was four to five per 10,000 children (Centers for Disease
Control and Prevention, 2007a), but research published in 1999 suggested that it may be actually
somewhere between 30 to 60 per 10,000 children or around 1 in 166 (Fombonne, 1999). Some
researchers and parent groups in the U.S. believed this data was evidence that autism was an
epidemic (Fombonne, 1999). In 2007, the Centers for Disease Control and Prevention (CDC)
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published the first prevalence rates from multiple sites in the U.S. using the diagnostic criteria
from the Diagnostic and Statistical Manual of Mental Disorders-IV -Text Revision. They
reported that 1 in 150 children had an ASD diagnosis in 2002 (CDC, 2007b). In 2009, the CDC
published prevalence rates reporting that 1 in 110 children were diagnosed with an ASD in 2006
(CDC, 2009a), up from their previous estimates. With the release of these prevalence rates, CDC
has called ASDs “an urgent public health concern” (CDC, 2009a, p.1), but has not been able to
confirm whether prevalence rates are truly increasing or if the rates have increased due to the
changes in diagnostic criteria over the years. Nevertheless, the largest autism advocacy groups
began referring to autism as an epidemic and argued that it deserved to be recognized as a public
health priority in terms of research and services (Autism Society of America, 2007; Autism
Speaks, 2007).
Perhaps the most puzzling and controversial issue surrounding autism has been the
suggested link between vaccines and autism. In 1998, a Lancet journal article presented findings
that demonstrated a link between the measles virus and autism, suggesting that the vaccine for
measles, mumps, and rubella (MMR) caused autism. At a press conference from the Royal Free
Hospital in London, the study’s main author, Andrew Wakefield, posited that giving children
individual MMR vaccines in three separate doses at annual intervals would be a safe alternative
to the current MMR vaccine. It should be noted that 10 of Wakefield's 13 co-authors disavowed
the findings of the study in 2004, his claims in the article have been refuted by a substantial body
of research, and Lancet retracted the article in 2010 (DeNoon, 2010). However, after
Wakefield’s study was published in 1998, MMR vaccination rates in Britain fell from a high of
92% to below 80% in 2003 (Lewis & Speers, 2003). Attempts to explain the fall of vaccination
rates point to the media’s coverage of Wakefield’s findings. One focus group study found that
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“the media reports about MMR had affected most parents’ immunization decisions, except for
those few who were already committed to their views” (Lewis & Speers, 2003, p. 914). Research
on the subsequent MMR media coverage in Britain found a direct relationship between the level
of media coverage and public concern (Lewis & Speers, 2003). Another study suggested that
perceived safety of the MMR vaccine fell after periods of media coverage in October 2000 and
March 2001, but rose again once media coverage declined (Lewis & Speers, 2003).
The MMR vaccine and autism media coverage in Britain and the subsequent decline in
vaccination rates demonstrate the power of the mass media to contribute to potential public
health crises. So, could that happen in the United States (U.S.)—or has it already happened? The
measles vaccine first became available in the mid-1960s and before that time, measles caused
450 reported deaths and 4,000 cases of encephalitis annually in the U.S. Endemic measles
transmission was eliminated in the U.S. after the vaccine became available (CDC, 2008).
However, between January and July 2008, 131 measles cases were reported to the CDC
compared with an average of 63 cases per year between 2000 and 2007 (CDC, 2008). According
to the CDC (2008), the number of measles cases reported between January and July 2008 was
the highest year-to-date since 1996. Among those measles cases reported during the first 7
months of 2008, 76% occurred in people younger than 20 years of age and 91% were
unvaccinated or of unknown vaccination status. So the idea of a return of measles due to vaccine
refusal is of great concern to U.S. government agencies such as the CDC who are charged with
protecting the public’s health. In March 2010, a Pediatrics article reported that 1 in 4 surveyed
parents in the U.S. in January 2009 believed that some vaccines cause autism (Freed, Clark,
Butchart, Singer, & Davis, 2010) despite overwhelming consensus in the medical and scientific
community that vaccines do not cause autism (Institute of Medicine, 2004). Parents were not
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asked about their media viewing habits or if seeing or hearing specific media stories influenced
their beliefs about autism. However, 81% of parents who believed that some vaccines cause
autism reported that they had heard or read about problems with the MMR vaccine (Freed et al.,
2010).
Current mass communication literature focuses on analyses of print media coverage of
the debate over whether vaccines cause autism. However, only limited research is available
about how other autism-related topics (e.g., prevalence rates and potential causes of autism other
than vaccines) are covered by the news media. Furthermore, no research is available on
broadcast media coverage of autism in the U.S. The influence of television has been studied
since its invention and is an important medium to examine. A recent analysis of health
information-seeking behaviors revealed that passive media outlets, such as television and radio,
were more likely to be the primary sources of health information for the individual who was
categorized as less health oriented (Dutta-Bergman, 2004). Furthermore, a recent survey
conducted by Pew (2008) showed that 29% of respondents reported watching nightly network
news. Respondents equally reported watching either NBC Nightly News or ABC’s World News
Tonight (14% each) and 8% reported watching the CBS Evening News. Television remains a
source of health information and television evening news continues to be watched among onethird of those surveyed in the U.S., thus, it deserves to be analyzed in terms of autism media
coverage. Therefore, this study attempted to fill in some of the gaps in autism media coverage
research by providing a content analysis of autism-related stories featured in national television
evening news broadcasts airing on ABC, CBS, and NBC. The purpose of the analysis was to
investigate how television news media framed autism causes and prevalence and contributed to
the public discourse on these issues from 1994, when autism was first recognized as a spectrum
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of disorders in the DSM-IV, through April 2010, the time of this study. This analysis will
hopefully lay the foundation for additional research to understand what, if any, role U.S. mass
media plays in influencing beliefs, attitudes, intentions, or behaviors of audiences in relation to
autism.
To better understand autism’s newsworthiness, it is important to first explore its history
as a disorder. The body of work contributing to the medical and psychiatric understanding of
autism is vast and fragmented. The events selected for this history were chosen based on a
review of texts which identified sentinel milestones and trends in autism research that has helped
establish diagnostic criteria, prevalence rates, and explore potential causes and risk factors.
Early Autism Accounts
Many scientists have argued that accounts of autistic-like behaviors can be found
throughout history in literature and legends, long before psychiatrists and researchers such as
Leo Kanner and Hans Asperger recorded their observations in the early twentieth century (Wing,
1997). Folktales of fairies replacing human babies with changeling children, who have voracious
appetites or the inability to speak, could actually be diagnosed as autistic with the current
criteria, some scientists insist. Legends about the followers of St. Francis of Assisi around the
thirteenth century mention a story of Brother Juniper, who lacked social awareness and sense and
would now likely be diagnosed with Asperger’s syndrome (currently on the spectrum of autistic
disorders). Prominent psychiatrist Sula Wolff (2004) wrote in her article on the history of autism
about “wolf children,” or children discovered in the wild during the 1800s who were found to be
mute, insensitive to cold, and walked on all fours. There is much speculation, she says, that these
cases were perhaps some of the first records of children who had what would now be considered
autism. One of the most celebrated “wolf children” was Victor, described by young French
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physician Jean Itard as the “wild boy of Aveyron.” Victor was discovered naked and covered
with scars in the woods of Aveyron, France around the age of 11 or 12. He initially presented
with an expressionless gaze, melancholy, sensitivity to loud noises, lack of imitation of others,
gluttony, and made only guttural sounds. Itard attempted to educate and “humanize” him over a
period of several years and made some progress. Psychiatrists J.K. and Lorna Wing say that
while Victor was deemed an “idiot” who had been abandoned by his family for that reason, he
showed most of the diagnostic features of autism (Wing & Wing, 1966).
These myths and early accounts are discussed in much of the literature about autism and
are important to mention because they demonstrate that the autistic tendency existed throughout
history. Today’s scientists use these accounts to explain that autistic behaviors have always
existed, but those who exhibited them were labeled as insane, “idiots” and/or as mythological
creatures. These accounts, factual and fictitious, also demonstrate that individuals exhibiting
what we would now describe as autism-like behaviors seem to have exerted a fascination worth
noting for the public throughout history (Wing, 2005). Despite these early accounts, the
connection between them, as well as other stories that attempted to explain weird or strange
behaviors in children, were not made until the late nineteenth century when British psychiatrist
Henry Maudsley posited that children who exhibited such behaviors could be afflicted with what
he called childhood psychosis. In the first half of the twentieth century researchers in the field of
abnormal child development began defining subgroups within childhood psychoses. It was
through this work that one might say that autism was discovered. The following section
discusses the work of those researchers who observed and described these behavior patterns and
labeled them autism.
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Labeling and Describing Autism
Prominent Swiss psychiatrist Eugen Bleuler, who studied schizophrenia, first introduced
the term “autism” in 1911. According to Bleuler, autism (from the Greek word autos or ‘self’)
describes how a person detaches from outer reality and immerses in an inner life. Influenced by
Freud’s notion of autoeroticism, Bleuler believed that autism was used as a defense mechanism
to avoid the conflicts between desires and reality that occur with schizophrenia. According to
Bleuler, autism is a fundamental but secondary symptom of schizophrenia (Parnas & Bovet,
1991). His description of autism included a variety of clinical manifestations: social withdrawal,
emotional indifference, inappropriate behaviors, and idiosyncratic beliefs and values
(Stanghellini, 2001). Bleuler’s work led to years of research about autism and its relation to
schizophrenia, but it is often ignored in the context of the current autism definition because of
that focus.
While work continued on autism and schizophrenia, it was Austrian Leo Kanner’s
adoption and redefinition of the term “autism” that led to its classification as a distinct disorder
that most closely resembles today’s definition of autism. Kanner’s 1943 article “Autistic
Disturbances of Affective Contact” first published in Nervous Child is described as one of the
few scientific papers that has stood the test of time and has received an honored place in the
history of psychiatry (Rutter, 1985). The article presented case studies of 11 children (eight boys
and three girls) under the age of 11, most of whom he had carefully observed since 1938 while
working at Johns Hopkins University. Setting the tone for the cases, he says “there have come to
our attention a number of children whose condition differs so markedly and uniquely from
anything reported so far, that each case merits—and, I hope, will eventually receive—a detailed
consideration of its fascinating peculiarities” (Kanner, 1943/1985, p. 11). Following the riveting,
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detailed accounts of each child’s case, he notes the emergence of essential common
characteristics among all of the children that form a unique syndrome, and who previously would
have been diagnosed as schizophrenic or been labeled feebleminded. He stressed that
fundamental to this disorder is the children’s inability to relate to themselves from the beginning
of life, distinguishing it from childhood schizophrenia, which he argued begins after a period of
average development. Parental accounts of their children as having always been “like a shell,”
“acting as if people weren’t there,” and “acting almost as if hypnotized” gave rise to Kanner’s
thoughts that this syndrome was unlike schizophrenia in children or adults. He stated that this
syndrome is different because “it is not a ‘withdrawal’ from formerly existing participation.
There is from the start an extreme autistic aloneness that, whenever possible, disregards, ignores,
shuts out anything that comes to the child from the outside” (Kanner, 1943/1985, p. 41). In
addition to the extreme autistic aloneness, Kanner listed as the universal characteristics the
inability to use language for communication, excellent memory, literalness, delayed echolalia
(described as parrot-like repetitions of heard word combinations that the child stores and utters at
a later time), and monotonous, repetitive motions and behavior. He concluded that these 11
children “have come into the world with innate inability to form the usual, biologically provided
affective contact with people, just as other children come into the world with innate physical or
intellectual handicaps….For here, we seem to have pure-culture examples of inborn autistic
disturbances of affective contact” (p. 50).
In addition to supposing that autism has a biological origin, Kanner’s first publication
about autism also introduced a controversial hypothesis for a social environmental cause of
autism that supposes cold, emotionless parents are the cause of autism. He noted among the 11
children:
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…there are very few really warmhearted fathers and mothers….Even some of the
happiest marriages are rather cold and formal affairs. Three of the marriages were dismal
failures. The question arises whether or to what extent this factor has contributed to the
condition of the children. The children’s aloneness from the beginning of life makes it
difficult to attribute the whole picture exclusively to the type of the early parent relations
with our patients (Kanner, 1943/1985, p. 50).
This hypothesis was discussed further in a 1949 publication in which Kanner coined the term
“refrigerator mother.” In his memoir, Leon Eisenberg (2001), who trained with Kanner, stated
that the concept of an inborn disturbance was not welcome within the field. “The rediscovery of
the impact of severe maternal deprivation on child development brought psychogenesis to the
fore. When Kanner coined the term ‘refrigerator mother,’ his view of autism became more
fashionable; the presumption was that the refrigerator mother produced a frozen child” (p. 745).
This hypothesis also received significant and lasting attention among the public thanks to the
work of Bruno Bettelheim, a psychoanalyst who published multiple articles in popular
magazines as well as his book The Empty Fortress: Infantile Autism and the Birth of Self. He
suggested that autism develops as a response to extreme negative feelings shown by the parent
and likened the response to that of inmates of concentration camps (Rutter, 1968/1985). The
“refrigerator mother” hypothesis has since been discredited and it is now the belief that what was
observed as unusual features in parents of children with autism were due to shared genes (Wolff,
2004).
After his initial publication in 1943, Kanner received much recognition and praise. His
name has become synonymous with autism and in addition to his coining the term “early
infantile autism,” the disorder was also referred to as “Kanner’s autism” or “Kanner’s
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syndrome.” Researchers credit his superb skill at observing and recording behavior for the reason
that his original description has withstood the test of time and scientific review (Donnellan,
1985). It should be noted that around the same time of Kanner’s article, Austrian pediatrician,
Hans Asperger described four cases of what he called “autistic psychopathy.” He noted that
some of these children had extraordinary gifts in math and science, but lacked the ability to form
proper social and emotional relationships. Asperger’s complementary work to Kanner’s did not
get the same recognition until 1981, when Lorna Wing published her seminal paper about the
pattern of behavior that had been described by Asperger. She called it Asperger’s syndrome,
which is often referred to as high functioning autism. Many believe that Asperger did not receive
the same recognition because his work was published in German and not readily available to the
English-speaking world (Wing, 2005).
While researchers have regarded Kanner’s original description and terminology over time
as accurate and clear, the body of “autism” research at the time of its publication lacked unifying
principles. Edward Ornitz (1973), who reviewed childhood autism in clinical and experimental
literature, points out that at least six major diagnostic rubrics were used to describe individuals
(specifically young children) with the set of symptoms that we now call autism. Adding to the
confusion was Kanner’s decision to use the term “autism” because of its previous association
with schizophrenia. Kanner admits that the decision to use the term “autism” was done so
reluctantly. The following is a lengthy citation, but one of great importance, because it explains
why and how he chose to use the term autism:
All this does not seem to fit in with Bleuler’s criteria for autism. There is not withdrawal
in the accepted sense of this word and a specific kind of contact with the external world is
a cardinal feature of the illness. Nevertheless, in full recognition of all this, I was unable
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to find a concise expression that would be equally or more suitably applicable. After all,
these children do start out in a state that resembles the end result of later-life withdrawal
and there is a remoteness at least from the human portion of the external world. An
identifying designation appeared to me to be definitely desirable because, as later events
proved, there was danger of having this distinct syndrome lumped together with a variety
of general categories (Kanner’s unpublished autobiography, as cited by Donnellan, 1985,
p. 2).
Kanner’s use of the term “autism” was indeed confused with Bleuler’s concept of autism as well
as others who associated autism with schizophrenia (Ornitz, 1973). In fact, much of the work that
followed Kanner’s original publication focused on establishing criteria for separating the
diagnosis of autism from a host of other labels for mental impairments (Donnellan, 1985). It was
not until 1980 that autism was included as a separate diagnostic condition from childhood
schizophrenia in the third version of the American Psychiatric Association’s (APA) Diagnostic
and Statistical Manual of Mental Disorders (DSM-III), the standard by which mental disorders
are diagnosed in the U.S.
Autism: A Distinct Disorder
The journey of the classification of autism as a distinct disorder in the DSM illustrates the
widespread conflicts, not only in autism research, but in the field of psychiatry as well, which
struggled to be recognized as a legitimate discipline within the greater medical discipline. The
publication of DSM-III in 1980 has been called the most important psychiatric publication to
appear between 1970 and 1980 and has been declared to be the most significant factor in
promoting the “remedicalization” of American psychiatry (Wilson, 1993). The
“remedicalization” of American psychiatry refers to the shift from a biopsychosocial model
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informed by psychoanalysis, sociological thinking and biological knowledge to a research-based
medical model, often called a biomedical model. Psychiatrist Arnold Ludwig summarized the
general reputation of psychiatry in the 1970s in his essay for the Journal of American Medical
Association: “Psychiatry has become a hodgepodge of unscientific opinions, assorted
philosophies, and ‘schools of thought,’ mixed metaphors, role diffusion, propaganda, and
politicking for ‘mental health’ and other esoteric goals” (p. 603). For autism and its progression
in psychiatry, this was the case as well. Kanner reflected in his unpublished memoirs that autism
had become quite “fashionable” amidst the confusion in the field:
[I]t became a habit to dilute the original concept of infantile autism by diagnosing it in
many disparate conditions which show one or another isolated symptom found as a part
feature of the overall syndrome. Almost overnight, the country seemed to be populated
by a multitude of autistic children, and somehow this trend became noticeable overseas as
well. Mentally defective children who displayed bizarre behavior were promptly labeled
autistic…. (Donnellan, 1985, p. 3).
Kanner’s reflections illustrate the notion that in the 1950s and 1960s, schizophrenia diagnoses
were quite common, and in children, that included autism (Wolff, 2004). These diagnoses
continued throughout the 1960s and 1970s because psychiatrists, pediatricians, and general
practitioners lacked a unifying language and set of criteria for diagnosis (Rutter, 2005). In 1980,
with the help of many biomedical autism experts, the APA added autism to the DSM-III as a
separate condition from childhood schizophrenia and included six mandatory criteria for
diagnosis. The APA included infantile autism as a part of a class of disorders called Pervasive
Development Disorders (PDD). The six mandatory criteria for diagnosing infantile autism were
listed as follows:
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1. Onset before 30 months of age;
2. Pervasive lack of responsiveness to other people;
3. Gross deficits in communication skill;
4. Peculiar speech patterns, if speech is present;
5. Bizarre responses to aspects of the environment; and,
6. Absence of delusions, hallucinations, loosening of associations, and incoherence.
(APA, 1980, p. 89).
Despite the monumental accomplishment of establishing these criteria for autism, many felt that
the descriptor infantile and emphasis on the condition in very young children was problematic
because it is a lifelong condition.
Major revisions were undertaken in the DSM-IIIR, published in 1987, to address these
issues. The APA changed “infantile autism” to “autistic disorder” to reflect that it is a lifelong
condition. In the DSM-IIIR, the criteria also were expanded to a very detailed list of sixteen
(eight of which were required for a diagnosis) to encompass developmental changes that can
occur across the lifespan. Age at onset was also dropped as a diagnostic feature. Another
category within PDD, called Pervasive Development Disorder-Not Otherwise Specified (PDDNOS), was added. According to the criteria, PDD-NOS was a diagnosis used when some
impairments were observed in social interaction and of verbal and nonverbal communication
skills, but the criteria were not met for Autistic Disorder, Schizophrenia, or Schizotypal or
Schizoid Personality Disorder (APA, 1987). Child psychiatrist and primary investigator for APA
autism research projects Fred Volkmar argued that while the DSM-IIIR was an improvement,
various studies showed a high rate of false positive cases (Volkmar et al., 1994). He also pointed
out that the World Health Organization’s International Statistical Classification of Diseases and
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Related Health Problems-10 (ICD-10) published in 1992 differed from the DSM-IIIR in what
was included in the pervasive developmental disorders class. The ICD-10 included Rett
syndrome, Childhood Disintegrative Disorder, and Asperger syndrome within PDD. Volkmar
ultimately spearheaded the efforts to conduct a large field trial to better understand the reliability
and validity of the criteria in the ICD-10, DSM-III and DSM-IIIR that would address these issues
for the next version of the DSM.
Volkmar et al. (1994) concluded that the DSM-IIIR criteria were associated with more
false positive diagnoses and that the ICD-10 criteria proved the best overall for autism. They
recommended that the DSM-IV use the ICD-10 entry for PDD. Published in 1994, the DSM-IV
expanded its definition and conditions within PDD to reflect that of the ICD-10:
Pervasive Developmental Disorders are characterized by severe and pervasive
impairment in several areas of development: reciprocal social interaction skills,
communication skills, or the presence of stereotyped behavior, interests, and activities.
The qualitative impairments that define these conditions are distinctly deviant relative to
the individual's developmental level or mental age. This section contains Autistic
Disorder, Rett's Disorder, Childhood Disintegrative Disorder, Asperger's Disorder, and
Pervasive Developmental Disorder Not Otherwise Specified. These disorders are usually
evident in the first years of life and are often associated with some degree of Mental
Retardation…. (APA, 1994, pp. 70-71).
The DSM-IV also reflected Lorna Wing’s (1981) idea that autism is actually a spectrum of
disorders (Autistic Disorder, Rett’s Disorder, PDD-NOS, Asperger syndrome, etc.) that are
related, but vary in severity. Diagnosis depends on which and how many sub-criteria within each
of the three major impairments the person has. A person will be diagnosed with autism if he/she
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meets at least eight of the DSM-IV’s sub-criteria. A person will be diagnosed with Asperger
syndrome if he/she only meets five or six different sub-criteria (APA. 1994). The next revision
of the manual, the DSM-V, is scheduled for publication in 2012.
The implications of the classification of autism as a distinct disorder are still being
debated. From Kanner’s strict criteria for infantile autism, reflected in autism’s first appearance
in the DSM in 1980, to the current DSM-IV definitions, which present autism as a spectrum of
disorders that include Asperger syndrome and other developmental disorders, the way autism is
diagnosed has certainly changed. Having consistent criteria for diagnosis has enabled scientists
to gather better samples of people with autism to conduct surveillance in terms of prevalence as
well as research in terms of causes and risk factors. The next two sections will explore how
changes in the ways that prevalence has been determined is related to arguments about the causes
of autism and will provide a better understanding for the landscape in which the media have
framed autism.
Autism Prevalence and Rates
Given the changing definitions and criteria for diagnosing autism or autism spectrum
disorder (ASD) as discussed in the previous section, determining its (or their) prevalence has
proven to be equally as challenging. Prevalence is the number of cases of a disease or condition
among a defined group of people during a specific time period and provides an estimate of the
probability that an individual will have the disease or condition at a point in time (Hennekens &
Buring, 1987). Prevalence measures are useful for health providers, educators, and policy makers
so that the public health impact of a specific disease within a community can be assessed to plan
services (for example, education and therapies) for those living with the condition. Also,
monitoring a condition in the same way over time allows scientists and researchers to find out
whether the prevalence of a disease or condition is increasing, decreasing, or staying the same
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(CDC, 2009b). Monitoring or determining prevalence over time to determine if autism or ASDs
have been increasing, decreasing or staying the same has proven to be difficult.
The first attempt to determine prevalence of autism and autistic-like conditions in a large
population of children living in a defined geographical area began in the mid-1960s with Victor
Lotter’s study of eight-to ten-year olds in Middlesex County, England (Wing, 1993). It is
important to review this first attempt because it illustrates how the lack of unifying criteria for
diagnosing autism has shaped prevalence data and continued to shape prevalence data, which has
implications for services and, perhaps, awareness of autism for the public and affected families.
Despite the lack of unifying criteria for diagnoses, Lotter felt that determining prevalence would
“produce data which indicate fruitful directions for further research, as well as providing useful
administrative information and permitting the examination of clinical hypothesis,” (Lotter,
1966/1985, p. 107). Lotter based his case definitions on criteria mainly developed by Kanner.
Children were screened using a 22-item behavioral questionnaire that was sent to schools and
other agencies who dealt with children in the area. The questionnaire covered speech,
movements, social behavior, and repetitive-ritualistic behavior. To increase the thoroughness of
his case-findings, he also screened medical, psychological, and educational records of
“handicapped” children as defined by the Education Act of 1944, which included children who
were blind, partially sighted, deaf, partially deaf, “educationally subnormal,” epileptic,
physically handicapped, or had speech problems. Within his prevalence rates, Lotter
differentiated between the 2.0 per 10,000 that exhibited Kanner’s core criteria and the 2.5 per
10,000 with a less consistent pattern of the criteria. Further, he gave a prevalence of 2.8 per
10,000 for those he called “non-autistic” but who exhibited some autistic features. Researchers
argue that if these data were analyzed using current ASD criteria, the overall autism prevalence
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rate for Lotter’s study would be 7.3 per 10,000 as compared to the 4.5 per 10,000 Lotter reported
(Rutter, 2005). This study exemplifies the problems of not having established consistent
diagnostic criteria for decades of autism research. Similar problems arose as others attempted to
determine prevalence in other populations.
In 1993, Lorna Wing reviewed sixteen studies of the prevalence of autism in defined
populations in Europe, the U.S., and Japan and found prevalence rates varied from 3.3 to 16.0
per 10,000. She speculated that differences may have been the result of variations in
interpretations of the diagnostic criteria, “even if real variations exist” (Wing, 1993, p. 71). In
fact, for many years, little was known about the prevalence of ASD in the U.S. because only four
U.S. population-based studies of autism had been conducted in the 1980s and 1990s (YearginAllsopp et al., 2003). Three of these studies (North Dakota, Utah, and Northern Arkansas) found
very low prevalence rates (for example, 4 per 10,000 children). In 1998, the fourth study of
prevalence took place in Brick Township, New Jersey, and reported a higher rate than any
previous U.S. study. They found that 40 per 10,000 three- to ten-year-old children had autistic
disorder. In 1999, Canadian psychiatrist and epidemiologist Eric Fombonne reviewed 23 studies
from around the world that were published between 1966 and 1998. His research suggested that
the rate for all pervasive developmental disorders was somewhere between 30 and 60 per 10,000
(Fombonne, 1999). From these data, advocacy groups and researchers began using the figure one
in 166 as a generalizable number of people with autism, but the data were not U.S. specific.
Many believed that these data were evidence that there is an epidemic of autism (Fombonne,
2001). An epidemic is the “occurrence of a disease in members of a defined population clearly in
excess of the number of cases usually or normally found in that population” (Friedman, 1980, p.
73). Further claims about the epidemic of autism were based on a report from California’s
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Department of Developmental Services (1999) that found between 1987 and 1998, the
population of people with autism increased from 4.85 to 9.37 percent. Fombonne examined the
methodology used by the California Department of Developmental services and found several
problems, including a lack of consideration for changes in diagnostic criteria over time
(Fombonne, 2001). To collect data for a more accurate prevalence of autism in the U.S., the
Children’s Health Act of 2000 authorized the Centers for Disease Control and Prevention (CDC)
to create the Autism and Developmental Disabilities Monitoring (ADDM) Network.
According to CDC, the ADDM Network is the largest multisite collaboration to monitor
ASDs in the U.S. with the following goals:
·

obtain as complete a count as possible of the number of children with ASDs in each
project area;

·

report comparable, population-based ASD prevalence estimates from different sites
and to determine if these rates are changing over time;

·

study whether autism is more common among some groups of children than among
others; and,

·

provide data to characterize those among the ASD population. (CDC, 2009b, p. 8)

Michael Rutter, who has been called the father of British child psychiatry (Pearce, 2005), argued
that the difference in all prevalence data reported thus far, including those from around the
world, “clearly demands an explanation” (Rutter, 2005, p. 2). In 2005, he set forth five criteria
for determining valid estimates of the incidence or prevalence of ASD:
1. A base population of sufficient size to provide a substantial number of individuals with
an ASD (so that the confidence interval will be narrow);
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2. A defined epidemiological population that covers all the individuals likely to be at risk
for an ASD;
3. Systematic standardized screening of the total population;
4. A focus on an age group for which it is known that diagnostic assessments are reliable
and valid; and,
5. Diagnosis by trained professionals using high-quality standardized research assessments.
(Rutter, 2005, pp. 2-3).
Using Rutter’s criteria to guide its attempt to determine accurate ASD prevalence in the U.S., the
CDC and its ADDM Network published its first report in 2007 that estimated approximately one
in 150 eight-year old children living in 14 communities had an ASD in the year 2002.
In their press release for the report in 2007, the CDC stated that the data were consistent
with the upper end of prevalence estimates from previously published studies (meaning the one
in 166 data), and that some of the communities had an estimate higher than those previously
reported (CDC, 2007a). However, CDC director Julie Gerberding stated that CDC was unable to
determine if there was a true increase in ASDs. CDC funded 14 states to collect prevalence data
through ADDM Network and said that these sites did not make up a nationally representative
sample. They cautioned against generalizing rates to every community in the U.S., but stated that
the study was designed to provide more consistent and reliable estimates (CDC, 2007b). Case
determination was completed in two phases: case ascertainment and clinician review. ADDM
investigators screened records at multiple sources that educated, diagnosed, treated, and provided
services for children with developmental disabilities and then a panel of clinicians with expertise
in identifying and assessing ASDs reviewed the abstracted information. They used the DSM-IVTR definition of autism to determine whether the identified children met the requirements of the

20
monitoring program and had an ASD (CDC, 2009). The U.S., for the first time, had prevalence
data from multiple sites that used the same methodologies and criteria for ASDs. Establishing
that one in every 150 children has an ASD using consistent methodology and criteria seemed to
be an important milestone in the history of the understanding of autism. In the report, CDC
interpreted and framed the data as an indication that ASD prevalence “is a continuing urgent
public health concern” (CDC, 2007b, n.p.). That CDC framed the data as an urgent public health
concern would seem to have implications for policy makers and healthcare providers, in terms of
funding and providing services for the thousands of children with ASD. It would also stand to
reason that it would have implications for the public, especially parents of young children, if it is
communicated to them as a real health threat or as an epidemic.
In October of 2009, a report from a study funded by the Health Resources and Services
Administration (HRSA) showed an autism prevalence of 110 per 10,000 children aged 3- to 17years in 2007 (Kogan et al., 2009). That’s roughly one in 90 children. However, the prevalence
was based on parental reports via a telephone survey. The study’s authors noted several
limitations including lack of clinical validation. Again, interpretation of these data and of the
report seems to vary among advocacy groups and the media, but no formal analysis of either has
been conducted to date. The HRSA report was followed by the second report from CDC and its
ADDM Network, using the same methodology as its 2007 study, and stated that in 2006,
approximately 1% or one in every 110 children living in 11 communities had an ASD. The
report stated the following in regards to whether an increase could be determined from the 2007
to the 2009 reports:
The average prevalence of ASDs identified among children aged 8 years increased 57%
in 10 sites from the 2002 to the 2006 ADDM surveillance year. Although improved
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ascertainment accounts for some of the prevalence increases documented in the ADDM
sites, a true increase in the risk for children to develop ASD symptoms cannot be ruled
out. On average, although delays in identification persisted, ASDs were being diagnosed
by community professionals at earlier ages in 2006 than in 2002 (CDC, 2009, p.1).
Despite the clarification on whether a true increase can be determined, as CDC states, there is no
doubt that more children are being identified and diagnosed with ASD. They stated “These
results indicate an increased prevalence of identified ASDs among U.S. children aged 8 years
and underscore the need to regard ASDs as an urgent public health concern” (CDC, 2009, p. 1).
As with their first report, CDC framed the data as an urgent public health concern. Interpretation
of these data and of the report which frames the data as an urgent public health concern among
various sources seems to vary among advocacy groups and the media, but no formal analysis of
either has been conducted to date. How the public, policy makers, and healthcare providers
interpret the prevalence data and perceive ASD as a health risk is important to analyze, but the
first step is to understand how prevalence data are being framed by the media. How the media
interpret and frame autism prevalence data can influence public perception of autism as well as
the potential causes of autism. For example, if the media frame autism as an epidemic, it can
potentially affect government policies and funding for funding autism research and services. Or,
if the media present information that suggests that autism prevalence has increased over the same
years that the number of required vaccinations have increased, then the argument for a
vaccination-autism connection is strengthened, despite the lack of scientific evidence to support
that claim. The next section explores the research that has been conducted about potential causes
and risk factors.
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Autism Causes of and Risk Factors
There has been research into the causes of autism, yet, it seems there is more controversy
than conclusion (Donnellan, 1985). One of the most controversial hypotheses early in the history
of autism research was around the cause of autism was the “refrigerator mother.” As mentioned
in a previous section, Kanner supposed that autism had a biological origin, but he also posited in
his 1943 article that cold, emotionless parents could cause autism. Fombonne (2003) points out
that Kanner’s observations could have indicated that there is a genetic cause, but the
predominance of psychoanalytical theories and the concentration on maternal deprivation in
post-World War II child psychiatry led to the “refrigerator mother” hypothesis that was
perpetuated by Bettelheim. In 1964, research psychologist and father of a son with autism,
Bernard Rimland, directly attacked the hypothesis with his book Infantile Autism. This sentinel
publication laid the theory to rest “so persuasively that no serious behavioral scientist has raised
it again” (Donnellan, 1985, p. 5). Point for point, he reviewed the arguments for the psychogenic
or emotional causes of autism and contended that the hypothesis lacked evidence-based scientific
rigor: “We are not saying that psychogenesis is an imaginary influence, we are merely saying
that there appears to be no evidence that it is anything but imaginary” (Rimland, 1964/1985, pp.
91-92). He pointed to the numerous cases of attentive parents who had children with autism and
the non-attentive parents who did not have children with autism. He also made the case for
biological causation noting that “there are a number of points of information which support the
hypothesis that autism may result from a rare recessive trait, or be otherwise determined by
biological factors” (Rimland, 1964/1985, p. 92). Among the nine points were two that suggested
a genetic component: high sex ratio (three or four boys for every girl) and twins with autism. His
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arguments have held the test of time and are regarded as the foundation for biological research in
autism (Holmes, 1985).
The research that has been conducted to determine the causes of and risk factors for
autism beyond emotional factors is vast and this review will try to cover them as succinctly as
possible. That it appears autism prevalence has been increasing (whether it is a true increase or
due to better diagnoses) has generated many hypotheses about the causes. Scientists are clearly
not certain about what causes ASD, but it is likely that both genetics and environment play a role
(National Institutes of Health, 2009). Regarding genes, twin studies, sibling studies, and other
family studies establish that a genetic susceptibility exists (Newschaffer et al., 2007). Research is
underway to identify specific autism risk genes; to date more than 100 genes have been studied
for their association with ASDs. According to an autism fact sheet from the National Institutes of
Health (NIH) (2009), studies of people with ASD have found irregularities in certain regions of
the brain and other studies suggest that people with ASD have abnormal levels of serotonin or
other neurotransmitters in the brain. All of this suggests that ASD “could result from the
disruption of normal brain development early in fetal development caused by defects in genes
that control brain growth and that regulate how brain cells communicate with each other,
possibly due to the influence of environmental factors on gene function” (NIH, 2009, n.p.).
Prenatal exposure to viruses such as cytomegalovirus and rubella have been linked to autism, but
most scientists agree that viral exposure is unlikely to account for all of the cases of autism
(Newschaffer et al., 2007). Three medications have been identified as potential autism risk
factors when given during pregnancy: thalidomide, prescribed in the 1950s and 1960s for
morning sickness and anxiety; valproic acid, an anti-epileptic drug that is also used for bipolar
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disorder and schizophrenia; and, misoprostol, which is used for labor-induced abortion and
related to ASD among survivors of the procedure (Newschaffer et al., 2007).
Some of the most controversial hypotheses about causes have concentrated on
demonstrating a link between vaccines and autism. As previously mentioned, Wakefield et al.
(1998) reported in The Lancet that the parents of 8 of 12 children with ASD and bowel
symptoms who were examined had the onset of behavioral symptoms within a mean interval of
6.3 days after receiving an MMR vaccine. Although the study never claimed to have definitively
proven a link between the MMR vaccine and autism, Wakefield’s interviews with the media
sensationalized the study and seemed to ignite a public panic in Britain. The media coverage of
this story and its effects will be discussed further in Chapter 2. Following the study’s release and
media hype, concerns about the study emerged. The reliability and validity of the study was
criticized because “there were no controls and no case validation” (Taylor, 2006, p. 515). Despite
the criticism, some parents and researchers remained concerned about the possible link. In the
U.S., the CDC and NIH engaged the Institute of Medicine (IOM) to examine the hypothesized
MMR-autism link and address other vaccine-safety issues “in order to give some guidance to
themselves, health care providers, researchers, and a concerned public” (IOM, 2001, p. 1). In
2001, the IOM concluded that “The evidence favors rejection of a causal relationship at the
population level between MMR vaccine and autistic spectrum disorders….A consistent body of
epidemiological evidence shows no association at a population level between MMR and ASD”
(IOM, 2001, p. 2). In 2004, 10 of Wakefield's 13 co-authors disavowed the findings of the 1998
study. In February of 2010, The Lancet retracted the story following the finding of the British
General Medical Council that said Wakefield and two colleagues acted dishonestly and
irresponsibly in conducting their research (DeNoon, 2010).
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The second controversial vaccine-autism link hypothesis centers around thimerosal, the
mercury-based preservative that was used in some vaccines. In 1997, Congressman Frank
Pallone attached an amendment to a U.S. Food and Drug Administration (FDA) reauthorization
bill which gave the FDA two years to compile a list of drugs and foods that contained
intentionally introduced mercury compounds (Offit, 2008b). The FDA asked for food and drug
makers to list the amount of mercury in their products. The analysis of the compiled data found
that by six months of age, infants could receive as much as 75 micrograms of mercury from the
preservative thimerosal used in various vaccines. Environmental mercury or methylmercury has
been shown to cause serious damage to the nervous system and the Environmental Protection
Agency (EPA) has safety guidelines for it (Offit, 2008b). However, thimerosal contains
ethylmercury. Unlike methylmercury, ethylmercury does not accumulate in the body or the brain
and is metabolized and cleared by the body (Miller & Reynolds, 2009). But, the EPA, the
Agency for Toxic Substances Disease Registry, and the World Health Organization do not have
standard safety guidelines for ethylmercury (Offit, 2008b). Having no guidelines, the FDA used
methylmercury-based standards to recommend that thimerosal be removed from routine infant
vaccines in the U.S. The CDC and the American Academy of Pediatrics promptly released a
joint statement on July 9, 1999 stating that while there was no evidence that thimerosal had
caused any harm, the groups agreed that vaccines containing thimerosal should be removed
given the concerns raised by EPA’s guidelines (Baker, 2008). The effort to remove thimerosal
from vaccines was largely complete by the summer of 2001. IOM was asked to review the
hypothesis that thimerosal-containing vaccines caused autism, adding to their previous charge to
look at the MMR vaccine link. In 2004, the IOM released their report stating that they had
reviewed the published and unpublished epidemiological studies regarding of potential biologic
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mechanisms by which immunizations might cause autism. The committee concluded that “the
body of epidemiological evidence favors rejection of a causal relationship between the MMR
vaccine and autism. The committee also concludes that the body of epidemiological evidence
favors rejection of a causal relationship between thimerosal-containing vaccines and autism. The
committee further finds that potential biological mechanisms for vaccine-induced autism that
have been generated to date are theoretical only” (IOM, 2004, p.1). Despite the IOM’s reports
and the lack of scientific literature demonstrating a link between autism and vaccines, the
controversy seems to persist especially among some communities of parents of children with
autism and organizations promoting cures for autism (Baker, 2008).
Currently, organizations such as Generation Rescue (2010, n.p.), which is led by
entertainer Jenny McCarthy, question the number and contents of vaccines given to children:
Parents should know that vaccines are never tested for their "combination risk", despite
the fact that children may get as many as 6 vaccines in a single visit to the doctor. And,
when it comes to vaccines, how can it be possible that one size fits all? What may present
as no risks for one child may present enormous risks for another… Many vaccines
contain other toxic substances including ethylene glycol (antifreeze), phenol (a
disinfectant dye), benzethonium chloride (a disinfectant), formaldehyde (a preservative
and disinfectant), and aluminum (another known neuro-toxin).
The number of shots a child may receive by age two has indeed increased from 11 in 1983 to as
many as 23 (CDC, 2010). Furthermore, a child might receive up to six shots during one visit to
the doctor. According to CDC,
The available scientific data show that simultaneous vaccination with multiple vaccines
has no adverse effect on the normal childhood immune system. A number of studies have
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been conducted to examine the effects of giving various combinations of vaccines
simultaneously. These studies have shown that the recommended vaccines are as
effective in combination as they are individually, and that such combinations carry no
greater risk for adverse side effects. (CDC, 2010, n.p.).
Thus, despite the preponderance of scientific data to the contrary, the autism-vaccine debate
continues. Baker (2008) argued that parents and clinicians “who have framed autism in
biomedical terms (such as immune or gastrointestinal dysfunction) have been critical agents in
promoting both the concept of the ‘autism epidemic’ and the primacy of vaccines as its cause”
(p. 248).
Framing autism as an epidemic can potentially affect government policies and for
funding autism research and services. In simple terms, the bigger a problem it is perceived to be,
the more government funding it generally receives. In December of 2006, President George W.
Bush signed The Combating Autism Act, which authorized nearly one billion dollars in
expenditures, over five years beginning in 2007, for autism research, screening, education, and
early intervention. Framing vaccines as the cause of autism can potentially result in public health
crises: 1 in 4 parents believe that vaccines cause autism and the number of measles cases
reported in 2008 were the highest since 1996 due to parents not vaccinating their children. While
some parents and advocacy groups have framed autism as an epidemic and caused by vaccines, it
is important to point out that no authoritative government agency such as the CDC or healthcare
provider organization such as the American Academy of Pediatricians has framed it in those
terms. Parents, government agencies, healthcare provider organizations, and advocacy groups
have certainly contributed the public discourse on a variety of autism issues including causes and
prevalence. Considering the media’s effect on the decline of MMR vaccines in Britain (Lewsi &
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Speers, 2003) and the recent survey reporting that 1 in 4 U.S. parents believe vaccines cause
autism, 81% of whom reported that they had heard or read about problems with the MMR
vaccine (Freed et al., 2010), this investigation seeks to understand the media’s contribution to the
public discourse on autism-related issues such as causes and prevalence. The next chapter
focuses on the analysis of mass media coverage of these autism topics thus far and the theoretical
grounding for that research and this thesis: agenda setting theory and framing theory.
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CHAPTER 2
THEORETICAL FRAMEWORK: AGENDA SETTING AND FRAMING
In order to examine the mass media’s contribution to the public discourse on autismrelated issues such as causes and prevalence, it is important to understand the theoretical
background that explains how mass media can influence public discourse. Agenda-setting theory
provides a nice framework to understand how through the selection of news stories, news
directors focus the public’s attention on some issues more than others and influence perceptions
of what are the most important issues. A related communication concept, framing, will be used to
explain how the mass media promote a particular definition of an issue through selection,
emphasis, exclusion, and elaboration. Current research related to mass media coverage of autism
is also discussed to demonstrate what is currently known about how media frame autism and
illustrate the gaps in knowledge around this specific topic that this thesis aims to fill.
Agenda-Setting
Decades of research on the long-term implications of journalism show that media
audiences not only learn factual information from exposure to news, but that people also learn
about the importance of topics in the news based on what topics the media covers. Cohen (1963)
observed that the news media do not tell people what to think, instead they tell people what to
think about. The ability to influence the importance or salience of topics on the public agenda is
called the agenda-setting role of the media (McCombs, 2004). Maxwell McCombs (2004), one of
the founding fathers of agenda-setting theory, explains that for all news media, the repetition of a
topic on a daily basis is the most powerful message of all about its importance. Newspapers
provide cues about the importance or salience of the topics on their daily agenda with their
decisions on the lead story, the size of a headline, and the length of a story while television news
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media provide cues by merely mentioning an issue in their broadcast because of the format as
well as placement in the broadcast and by the amount of time spent on the story. McCombs
(2004) explains how these salience cues affect the public: “Establishing salience among the
public, placing an issue or topic on the public agenda so that it becomes the focus of public
attention and thought – and, possibly, action – is the initial stage in the formation of public
opinion.” (p. 2). In terms of story length, the typical evening news segment runs, on average,
between one-and-a-half to two minutes and may be extended for important news items (Watkins,
2001). Regarding placement, issues or news items perceived as the most important for that day
are typically the lead story. “Hard” news items are generally presented near the beginning of the
broadcast. According to Jamieson and Campbell (1997), “hard news is the report of an event that
happened or that was disclosed within the previous twenty-four hours and treats an issue of
ongoing concern” (p. 40). “Soft” news items are placed near the end and tend to address more
human interest stories and may include more humorous or novel stories (Watkins, 2001).
Most of McCombs’ research, as well as that of others who used agenda-setting theory to
explain media effects, has focused on the media’s role in emphasizing political issues and
subsequent voter behavior and political attitudes. But within the last 20 years, more agendasetting researchers have been examining other issues, such as health-related behaviors and
perceptions (Ogata Jones, Denham, & Sprinston, 2006). These include the agenda setting role of
the media regarding smoking (Sato, 2003), health care reform (Hacker, 1996), AIDS policy
(Backstrom & Robins, 1998), and breast cancer screening (Ogata Jones et al., 2006).
Given that many journal articles are published every month with research findings that
have the potential to impact the public’s health, and many organizations promote and advocate
for thousands of health conditions, how do the media decide which journal articles or health
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issues are newsworthy? This question is of particular interest for this study. In a recent survey of
health and medical science reporters and editors, Viswanath et al. (2008) found that the initial
idea for a health-related story most often originates from a news source suggestion. A news
source is defined as “a person with whom the reporter is frequently in contact with to obtain
information” (p.769). Reporters also named resources such as press conferences or press releases
and wire service items as generators of initial ideas. There were differences among reporters
depending on their reach (national versus local) and medium (broadcast vs. print). National news
reporters said they most often get their initial idea for a story from scientific journals; local news
reporters said they rely most on suggestions from a source. Broadcast news journalists reported
that they rely on a suggestion by a source or wire services more often than print reporters.
Regarding news sources, national reporters mentioned using scientists and researchers most
often. Broadcast journalists were significantly more likely to report using scientific journals for
their initial ideas compared with print reporters. Broadcast journalists said that potential for
public impact, new information and development, and ability to provide human interest were the
most important criteria for determining newsworthiness. For the purposes of this research, which
seeks to investigate television broadcast news, it is important to note that these three criteria were
rated significantly higher for broadcast journalists than print reporters. This suggests that
broadcast stories related to autism might differ from print stories, which have been the primary
focus of previous research on media coverage of autism. Studies of how reporters “decide” what
is news and how they “construct” news can be helpful in the understanding of the agenda-setting
role of the media and provides a transition for a discussion in the next section on another
communication concept: framing.
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Framing and Second-Level Agenda Setting
That broadcast journalists determine newsworthiness of a health topic based on its
potential for public impact, new information and development, and ability to provide human
interest is not surprising because journalism is grounded in storytelling and is constructed as
such. Walter Lippmann’s opening chapter of Public Opinion argued that public opinion responds
not to the environment, but to the pseudoenvironment constructed by the news media (McCombs
& Reynolds, 2002). He also argued that the news media are a primary source of the pictures in
our heads (McCombs, 2004). Both of Lippmann’s arguments speak to the process by which the
media’s stories are told and organized in addition to the media’s role in agenda-setting. Agendasetting theory researchers have proposed that media messages contain an agenda of both objects
and attributes. In the context of politics, objects are equivalent to issues or candidates and
attributes are properties associated with the objects. For this study, the object or the issue is
autism and the attributes include the controversy about what causes autism, the vaccine-autism
hypothesis and the characterization that autism is increasing. McCombs and Ghanem (2003)
argue that the objects and attributes presented in media vary in salience or importance—that is—
the media present some objects, such as autism, and attributes, such as the controversy related to
vaccines causing autism as more important for the public than other attributes. Further,
McCombs and Ghanem suggest that agenda setting has two levels: the first level is the
transmission of object salience from the mass media’s pictures of the world to those in our heads;
the second level is the transmission of attribute salience. This second level, attribute agenda
setting, illustrates that in addition to the media telling us what to think about, they also tell us
how to think about some objects. McCombs (2003) suggests that this is actually what other
scholars refer to as framing and that framing is a dimension of agenda-setting.
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McCombs (2004) defines framing as the central organizing idea for news content that
supplies a context and suggests what the issue is through the use of selection, emphasis,
exclusion and elaboration. Other scholars, such as Entman (1993), state that framing occurs
when the media select certain aspects of a topic and make them more salient in a communicating
text, in such a way as to promote a particular problem. Both, it seems, have similar definitions
for framing. However, Entman (1993) adds that frames have at least four locations in the
communication process: the communicator, the text, the receiver, and the culture. According to
Maher (2003), framing scholarship concentrates on the communicator’s framing or the
journalist’s framing of the text and agenda-setting scholarship focuses on the transfer of framing
salience between the text and the receiver (the public).
While many scholars have debated the differences, researchers from both traditions are
recognizing their common ground and see advantages to using both frameworks: agenda-setting
studies are increasingly measuring the transfer of framing from media to public and framing
studies are increasingly measuring audience effects (Maher, 2003). For the purposes of this
study, agenda-setting theory provides the framework for which to examine autism as a topic
covered by the media. Has coverage increased over time? Is its placement in evening news
broadcasts prominent? How much time do broadcasts devote to covering autism? Framing
provides the lens for exploring how the media covers autism and related issues: causes and
prevalence. According to Entman (1991, p.9), “the essence of framing is sizing—magnifying or
shrinking elements of the depicted reality to make them more or less salient.” Further, he says
that in texts such as evening news broadcasts, frames “are manifested by the presence or absence
of keywords, stock phrases, stereotyped images, sources of information, and sentences that
provide thematically reinforcing clusters of facts or judgments” (Entman, 1993, p. 52). Another

34
important concept described in the framing literature that is important for this study is the
applicability effect. Applicability refers to the audience’s acceptance that two concepts are
related after exposure to a media message that suggests there is a connection between two
concepts (Scheufele & Tewksbury, 2007). This effect is especially relevant for this study when
considering whether the media have framed autism as potentially caused by vaccines and/or as
an epidemic because of the potential public health implications associated with these frames.
Before testing for audience effects, however, it is important to know how often the media
connect autism with both vaccines and epidemics.
Like agenda-setting, much of the research related to framing has been conducted with
political media coverage, but it has been used to better understand the role of media portrayals of
a few health contexts (e.g., health reform, organ donation, breast cancer). Similar to the framing
of other social issues such as poverty and crime, research on the framing of public health issues
has shown once a health problem is discussed in the public sphere, responsibility for the health
problem is a main focus (Lawrence, 2004). The discussion of who or what is responsible for the
health problem can influence public opinion and policies. Nathanson (1999) adds that public
health policies are adopted in response to perceived danger and identifies dimensions of how
public health risks are framed for those purposes:
In any given case, risks may be portrayed as acquired deliberately or involuntarily (and
the victims as correspondingly culpable or innocent), as universal (putting us all at risk)
or as particular (only putting them at risk), as arising from within the individual or from
the environment, as visible or invisible. The most acceptable risks are universal, are
attributable to the external environment, and are incurred involuntarily by innocent
victims. (p. 446).
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This is particularly important when thinking about the framing of autism. If the media frames
autism as an epidemic, then that would imply that more children could be at risk than previously
thought—that it is, in a sense, universal (depending on the media’s and the public’s definition of
an epidemic). If the media portray autism as caused by vaccines or emphasize the connection
between autism and vaccines, then that would mean that autism is incurred involuntarily by
innocent victims because many state governments mandate vaccinations: i.e., there is someone or
something to blame. However, the general consensus among the scientific community around the
causes of autism is that both genetics and something in the environment play a role (National
Institutes of Health, 2009). The focus on genetics may not resonate as well with parents because
it suggests that they (or their genes) play a role—or that the parents are somehow to blame,
which harkens back to the time of the “refrigerator mother” hypothesis. For the media, it seems
that the autism-vaccine debate has set up a dramatic storyline ripe with just enough controversy
worthy of reporting, regardless of the overwhelming scientific evidence that vaccines do not
cause autism. Explaining the role of genetics may be too difficult for reporters and for the media
audience because they are complicated scientific topics. Emphasizing the potential role of
vaccines may be easier because the government requires most children to be vaccinated, which
affects most parents and would mean that more parents would be engaged by a story of this
nature. The next section will focus on the current literature related to both how autism has been
framed by the media and the impact of the mass media coverage of autism on public perceptions
and behaviors.
Mass Media Coverage of Autism
Interest in the analysis of news media coverage related to autism started when scientists
and others began to see the impact of the previously mentioned Wakefield study in the Lancet. In
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1998, the Lancet journal article presented findings that demonstrated a potential link between the
measles virus and autism, suggesting that the vaccine for measles, mumps, and rubella (MMR)
caused autism. After Wakefield’s study was published in 1998, MMR vaccination rates in
Britain fell from a high of 92% to below 80% in 2003 (Lewis & Speers, 2003). Attempts to
explain the fall of vaccination rates point to the media’s coverage of the issue. Lewis and Speers
(2003) conducted a content analysis of British print, television, and radio news coverage of the
controversy from January to September 2002. The analysis revealed that 69% of MMR stories
focused on a link between the MMR vaccine and autism and 58% of MMR stories mentioned
Wakefield’s proposal for three single vaccines. Despite the large body of scientific evidence that
disputes Wakefield’s findings, research indicating the safety of MMR was featured in only 37%
of stories. Lewis and Speers observed that the MMR vaccine became controversial during this
time period (January through September, 2002) because a BBC television program Panorama,
aired a broadcast titled “How safe is MMR” on February 3, 2002, taking up Wakefield’s theory
regarding the MMR vaccine. Wakefield and other colleagues also pre-published a paper in
Molecular Pathology that was made available when this broadcast aired. Reporting of a measles
outbreak in a middle-class London suburb also highlighted the controversy during this period of
time. Lewis and Speers note that this was not the first time the MMR vaccine had been under
media scrutiny (i.e., 1998), but that these events threw the vaccine back into the public spotlight
in 2002. To better understand whether a media agenda-setting effect was in play, Lewis and
Speers (2003) supplemented their content analysis with two national surveys of British adults.
Their surveys examined whether the general public was able to recall the dominant themes and
overall frameworks of autism news coverage. In both surveys, two-thirds of the respondents
(67%) indicated an awareness of the research showing that the MMR vaccine was unsafe and

37
recalled that autism was the focus of the research. Fewer than one in every four respondents were
aware that the majority of scientific evidence shows no link between MMR and autism. The
authors noted that the negative media attention and decline in public confidence in the MMR
vaccine seemed largely a British phenomenon. This attention to analysis of British media
coverage and effects related to autism and the MMR vaccine provides a starting point from
which researchers began to examine media coverage related to autism in the U.S.
In 2007, one of the few analyses of autism and the media in the U.S. examined autism
topics covered by the media from 1994 to 2004 and compared them to the autism topics covered
in the scientific literature and the autism topics that were receiving funding (Singh et al., 2007).
Brain and behavior research was identified as a main focus of new grants in autism research in
all samples examined from the U.S., Canada, and Britain (42% of the total grants) and as a main
focus in the scientific peer-reviewed literature (41% of papers). In stark contrast, brain and
behavior research accounted for merely 11% of articles about autism research in major
international print media in those same countries. The study’s authors also noted a paradox in
coverage of genetics research. Genetics research was identified as the second most frequently
identified category of new grants in autism research and represented 34% of the focus of the
scientific peer-reviewed literature. However, genetics research accounted for only 7% of the
print press articles. The greatest paradox identified by the study was that the media’s intense
focus on environmental causes and epidemiology research (48% of media articles) far exceeded
research grants (7%) and scientific peer-reviewed literature (13%). Singh et al. (2007) found that
this disproportionate reporting correlated with the high coverage of the Wakefield study. Among
all media articles with an environmental focus, 70% discussed the MMR vaccine and 40%
referred directly to the Wakefield study. Singh et al. (2007) point out that the media coverage of
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MMR can be viewed as a “reasonable reflection of the issues deemed most important by the
public…it could be argued that it is the funding agencies that are out of step: media coverage of
autism based on the controversy of MMR not only stimulated awareness of autism but also
highlighted the need for additional research in the causes and treatments of this disorder” (p.
158).
At the very least, the Singh et al. (2007) case study demonstrates that priorities of media,
science, and government can diverge, at least in terms of autism. The authors argue that this in
turn leaves the scientific community and government agencies at odds with the media in terms of
the perception of scientific data, which can ultimately influence public perception. The authors
conclude that their perspective is limited by several factors, including that their study did not
account for the television coverage of the issue, in which the stories of advocacy groups,
families, and celebrities are able to be told in a more captivating audio-visual format. Despite its
limitations, this research contributes to the small growing body of autism-related media coverage
analysis in that it highlights the importance of examining how media choose what is newsworthy
as it relates to autism research.
Clarke (2008) analyzed major national newspaper coverage of the autism-vaccine
controversy from February 1998 to June 2006 in Britain and the U.S. to better understand how
the media frames and “balances” the presentation of findings and coverage of the debate. Among
the most noteworthy of the study’s findings was the coverage pattern of the controversy:
relatively low coverage from 1998-2000, increased attention from 2001-2002, falling coverage in
2003, a spike in articles in 2004, and a steady decline in 2005 and 2006. Clarke found the
increased attention to those studies showing a link between autism and vaccines from 2001-2002
and 2004 among British newspapers especially troubling because it was a time when the

39
scientific consensus refuting vaccines was strengthened. According to the article, studies/claims
refuting that vaccines cause autism were significantly more likely to appear in newspapers from
the U.S. (41%) than in British newspapers (10%). Furthermore, newspapers from the U.S. did
not devote significant attention to studies/claims that vaccines cause autism by themselves in any
single year analyzed. In contrast, U.S. newspapers were far more likely to devote significant
attention to studies/claims refuting that vaccines cause autism by themselves, especially in 2002
and 2004-2006.
While the analysis of news media coverage related to autism has provided some insights,
it does not provide a complete picture of their contribution to the public discourse on the issue.
Most analyses focus on print media coverage and/or coverage of the MMR vaccine controversy
in Britain. The MMR vaccine and autism media coverage in Britain and the subsequent decline
in vaccination rates demonstrate the power of the mass media to contribute to potential public
health crises. Given that 1 in 4 parents surveyed in the U.S. believe vaccines cause autism (Freed
et al., 2010) warrants further examination of how the U.S. media have framed the hypothesis
along with potential causes that have received more scientific confirmation. As demonstrated in
Chapter 1, there are other issues that have potentially shaped the public’s understanding of
autism; how the media interpret and frame autism prevalence data can influence public
perception of autism as well as the potential causes of autism. For example, if the media frame
autism as an epidemic, it can potentially affect government policies and funding for funding
autism research and services.
Research Questions
As noted in the literature review, television news media provide cues of an issue’s
importance by placement in the broadcast and by the amount of time spent on the story.
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Therefore, the first set of research questions were designed to capture the salience of autism
related news stories.
RQ 1a: Did the frequency of autism-related television evening news stories increase,
decrease, or remain relatively stable during the study period?
RQ 1b: Did the placement of autism-related television evening news stories become
more prominent, less prominent, or remain relatively the same during the study period?
RQ 1c: Were there significant differences in the frequency of autism-related stories
between the networks (ABC, CBS, or NBC) regarding length of story as well as
placement?
As noted in the literature review, scientists are not certain about what causes autism, but
agree that it is likely that both genetics and environment play a role. Some of the most
controversial hypotheses about causes have concentrated on demonstrating a link between
vaccines and autism. Therefore, this second set of research questions were designed to
understand which hypotheses and research about potential causes have received the most
coverage and how the causes were framed.
RQ 2a: How frequently did autism-related television evening news stories mention or
focus on potential causes during the study period?
RQ 2b: What causes were addressed the most frequently?
RQ 2c: When an autism-related story included one cause, how frequently were other
causes also discussed?
RQ 2d: How frequently was each cause presented as 1) likely to cause autism, 2)
unlikely to cause autism, and 3) a potential cause, but with the suggestion that more
information is needed to determine if it causes autism?
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RQ 2e: Did the framing of vaccines as a likely cause of autism increase, decrease, or
remain relatively stable during the study period?
RQ 2f: Were there significant differences in the frequency of vaccine-related autism
stories between the networks (ABC, CBS, or NBC) during the study period?
RQ 2g: Were there significant differences in the frequency that the networks (ABC,
CBS, or NBC) framed vaccines as a likely cause of autism?
As noted in the literature, how the media interpret and frame autism prevalence data can
influence public perception of autism as well as the potential causes of autism. For example, if
the media frame autism as an epidemic, then it can potentially affect government policies and
funding for funding autism research and services. Therefore, the third set of research questions
were designed to examine what prevalence numbers, rates, or statistics the media used in
describing the number of people with autism, when they were used, and how they were framed
(e.g., as increasing, representing an epidemic or a public health concern).
RQ 3a: What prevalence/rates of autism were cited each year?
RQ 3b: How frequently did television evening news coverage suggest that autism
prevalence is increasing?
RQ 3c: How frequently was autism framed as an “epidemic” in television evening news
during the study period?
RQ 3d: How frequently was autism framed as a “public health concern” in television
evening news during the study period?
RQ 3e: Were there significant differences in the frequency that the networks (ABC,
CBS, or NBC) framed autism as increasing, an “epidemic,” or a “public health concern?”
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The fourth set of research questions were designed to examine who the media
interviewed in news stories, and more specifically, who the media interviewed about causes and
the hypothesis regarding vaccines causing autism. Although journalists sometimes are
eyewitnesses to events, they tell stories primarily through sources rather than through their own
observations (Singer & Endreny, 1993). According to Singer and Endreny (1993), journalists
select individuals to interview for a story based on who has authoritative personal knowledge
regarding an event and factors such as availability or access and suitability or newsworthiness.
Journalists ultimately decide which interviews and material from those they have interviewed are
incorporated into their news report. Examining who the media interviews, specifically about
cause and the hypothesis regarding vaccines causing autism, can help understand how these
issues are framed for the public. As noted in the literature review, despite the IOM’s reports and
the lack of scientific literature demonstrating a link between autism and vaccines, the idea that
vaccines causes autism seems to persist especially among certain communities of parents of
children with autism (Baker, 2008). If the media consistently interviews parents who believe that
vaccines cause autism and medical experts from the government or health professional
organizations who say vaccines are safe, then this could be viewed as framing the issue as
parents versus the government or the medical establishment for the public. The audience is left
having to decide whether they find information from parents or the medical
establishment/government more believable or credible based on interviews.
RQ 4a: Who was most frequently interviewed in autism-related stories in television
evening news during the study period?
RQ 4b: Who most frequently was interviewed in stories that mentioned or focused on
potential autism causes of autism in television evening news during the study period?
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RQ 4c: Who was most frequently interviewed about vaccines in television evening news
during the study period?
RQ 4d: Of those interviewed about vaccines, which categories of people were presented
most frequently as making a case for vaccines as a cause for autism and most frequently
making a case against vaccines as a cause of autism.
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CHAPTER 3
METHODS
As indicated in the literature review, a recent survey conducted by Pew (2008) showed
that 29% of respondents reported watching nightly network news. That is up slightly from the
2006 report showing 28% watched nightly network news. An equal number of respondents
reported watching either NBC’s Nightly News or ABC’s World News Tonight (14% each) and
8% reported watching the CBS Evening News. Therefore, this study examined the content of
television evening news broadcast from the largest networks: ABC, NBC, and CBS. Content
analysis involves examining texts to understand what they mean to people, what they enable or
prevent, and what the information presented to them does (Krippendorff, 2004). Content analysis
of health-related messages has proven to be a useful tool for those researchers within
communication and health fields especially for research that seeks to draw implications for
audience effects (Kunkel, 2009).
Selection of Broadcast Transcripts
The news reports were selected through a LexisNexis Academic Universe search for the
words “autism” and “autistic” in the headline of the broadcast transcripts section between
January 1994, when autism was recognized as a spectrum of disorders in the DSM-IV, to April
2010, the time of this study. The primary goal of this study was to understand the frequency and
prominence of autism-related stories throughout the study period and how autism prevalence and
causes were framed. Only stories that had “autism” or “autistic” in their headline were analyzed
(N=121). The focus of this study was to examine stories that have the greatest potential to impact
public opinion about autism, which is more likely to happen when autism is the primary focus of
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a news piece, and identified as such through a headline, than when autism is briefly mentioned
within a news story.
To test accuracy of search results, the data obtained from LexisNexis Academic Universe
were compared with the search results from the Vanderbilt Television News Archive. This
archive contains recordings and summaries of U.S. television news broadcasts from 1968 to the
present time. The Vanderbilt Television News Archive also provides an entire listing of all
stories appearing during a specific broadcast and the order in which they appear as well as the
amount of time spent on each story—both of which are important for determining saliency,
according to McCombs (2004), but neither of which were accessible through the transcripts
provided by LexisNexis Academic Universe. Thus, both sources were used. Because the
Vanderbilt Television News Archive provides the most extensive and complete archive of
television news, it was considered the standard by which additional searches were conducted in
LexisNexis Academic Universe to find transcripts that did not show up in the initial search. An
initial search of LexisNexis Academic Universe for “autism” and “autistic” in the headline from
January 1994 to January 2010 yielded 81 stories. In order to capture stories occurring after
January 2010 that may have acknowledged the Lancet’s retraction of the initial Wakefield et al.
study linking autism to vaccines on February 2, 2010, the study period was expanded from
January 1994 to April 1, 2010. Cross-referencing the stories with the Vanderbilt Television
News Archive and expanding the study period from January 1994 to April 2010 yielded 121
autism-related stories. Thus, the use of both sources ensured that more stories focusing on autism
in television evening news coverage were captured and analyzed.
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Coding Procedure
Each news broadcast story served as the unit of analysis for this study and the following
variables were coded within each autism news story (see Appendix A for the Content Analysis
Codebook and Appendix B for the Content Analysis Coding Sheet):
Prominence of autism-related stories. McCombs (2004) argued that television news
media provide cues about the importance or salience of the topics by the placement in the
broadcast and by the amount of time spent on the story. This study examined whether the
placement of autism-related stories has increased, decreased, or stayed the same during the study
period by coding each story as the lead story, before the first commercial or lead story after the
first commercial, last story, or other (defined as placement anywhere not included in the other
choices). This study also examined the length of autism-related stories during the study period by
coding the duration in 30-second intervals.
Causes of and risk factors for autism. Given the controversial nature of the research on
causes of autism, it is important to understand which hypotheses and research have received the
most coverage. Stories that included causes were coded as either mentioned in the story (but not
the main focus) or coded as the main focus of the story. If causes were either mentioned or the
main focus of the story, then each potential cause or risk factor (below) was coded as not
included, mentioned, or as the main focus of the story. The following potential causes were
coded:
·

Genetics or genes—Stories suggesting genes or genetic causes may include the words
“family history,” genes from mother or father, and/or twins or siblings. These stories
could also include the identification of “risk” genes or genes that have been identified by
scientist as increasing the risk for autism.
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·

Brain/Neurological Irregularities—Stories that suggest that irregularities in regions of the
brain is a cause of autism. This may also include mention of abnormal levels of serotonin
or other neurotransmitters as a cause of autism.

·

Prenatal Exposure to Viruses—This is defined as prenatal exposure to viruses as a cause
of autism. Some viruses that may be mentioned such as cytomegalovirus or CMV and
rubella.

·

Medications—This may include medications such as, but not limited to thalidomide,
valproic acid, and misoprostol as potential causes of autism.

·

Vaccines—This includes vaccines, such as, but not limited to, the vaccine for Measles,
Mumps, and Rubella or MMR; thimerosal, a preservative in vaccines; and/or the number
of vaccines given as a cause of autism.

·

Environment—This may include something in the environment that can cause autism.
This includes using the word “environmental” or “environment” and/or toxins, chemicals,
pollutants or pesticides.

·

Other—Other is defined as a cause or potential cause of autism this was not mentioned
above. The coder was asked to write in the cause if other was circled.
Then each factor that was coded as mentioned or main focus of the story was coded as

the “story suggests that the cause or risk factor is unlikely,” “story suggests that the risk factor is
likely,” or “the story suggests that not enough is known or it is inconclusive as a cause or risk
factor.”
Rates or prevalence of autism. Given the struggle to determine accurate criteria for an
autism diagnosis, which has in turn affected the ability to determine true prevalence, it is
important to examine how the prevalence data or rates/estimates have been characterized by the
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media to better understand their contribution to the public discourse on the issue. It is also
important to examine what prevalence numbers or rates the media uses in describing the number
of people with autism and when they were used. The following numbers were coded based on
prevalence rates identified in the literature review:
·

4.5 per 10,000 (first numbers reported in 1966 in England) (Lotter, 1966/1985)

·

67 per 10,000 (Brick Township, NJ numbers reported in 1998) (Yeargin-Allsopp et al.,
2003)

·

60 per 10,000 (Fombonne, 1999)

·

1 in 166 (Fombonne, 1999)

·

1 in 150 (CDC, 2007a)

·

1 in 90 or 1 in 91 (Kogan et al., 2009)

·

1 in 110 (CDC, 2009)

·

1% or 1 percent (CDC, 2009)

·

Other
After coding “Other” stories, the “Other” category was examined and when a figure was

identified at least 5 times, a new category was created. The estimated rate of 500,000 or 560,000
children with autism was added and coded because it was identified in stories at least 5 times.
This rate was previously identified in a CDC press briefing transcript when it released the 1 in
150 prevalence data. CDC stated that 1 in 150 prevalence corresponded to about 560,000
children ages 0 to 21 years (CDC, 2007c).
The stories were then coded as to whether or not they suggested that the rates/estimates
or prevalence of autism are increasing [no/yes]. In addition, the U.S. government has called
autism an “urgent public health concern,” while advocacy groups have used the term “epidemic.”
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The stories were coded to identify the frequency that each of these terms/phrases was included in
the stories.
Sources. Because this study is exploratory in nature and seeks to understand how the
media have contributed to the public discourse on autism, it was important to examine who the
media interviews in news stories. The following categories of people who were interviewed were
coded:
·

Government health officials—including doctors, epidemiologists, and scientists
from state governments as well as national government agencies such as the
Centers for Disease Control and Prevention (CDC), National Institutes of Health
(NIH), Environmental Protection Agency (EPA), the U.S. Department of Health
and Human Services (HHS), or the U.S. Food and Drug Administration (FDA);

·

Medical experts from hospitals, medical experts from advocacy or non-profit
organizations such as Autism Speaks, Cure Autism Now, or Autism Society of
America.

·

Parents of or family members of people with autism were coded as well as people
with autism.

·

Celebrities were included as well given that the influence of celebrities or public
figures on health knowledge, attitudes, and behaviors has been documented in the
cases of Katie Couric and colon cancer screening (Cram, Fendrick, Inadomi,
Cowen, Carpenter, & Vijan, 2003), ‘Magic’ Johnson and HIV prevention
messages (Flora, Schooler, Mays, & Cochran, 1996), and Nancy Reagan and
choice of surgery for breast cancer (Nattinger, Hoffmann, Howell-Pelz, &
Goodwin, 1998).
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·

Health professionals representing health professional organizations (such as the
American Academy of Pediatrics) were coded.

·

Leaders of advocacy or non-profit organizations such as Autism Speaks, Cure
Autism Now, Autism Society of America, etc. who were not labeled as having
medical degrees were coded. Researchers or representatives from universities
were coded. The category of “other” was provided for those individuals who were
identified in such a way that did not fit into the given categories.

·

Multiple categories could be coded, if, for example, the person interviewed was
identified in the transcript as a parent and a celebrity.

Each person interviewed was coded to identify whether they presented a message
suggesting there is no link between autism and vaccines (anti-link), presented a message
suggesting there is a link between autism and vaccines (pro-link), or presented no message
related to the subject of vaccines. This study used the same methods as Clarke (2008) to code for
“anti-link” or “pro-link.” “Anti-link” is defined as the person being interviewed indicates that a
link between autism and vaccines is improbable, unsupported by evidence, or disproved. “Prolink” is defined as the person being interviewed indicates that the theory or idea of vaccines
causing autism is possible, plausible, or probable. “Not sure” was also coded if the person
presented views that could be coded “pro-link” or “anti-link.” Following the coding of all stories,
the study author decided to change those items coded as “Not sure” to “pro-link.” The “pro-link”
definition states that the person indicates the theory of vaccines causing autism is possible. The
study author recognized that a person who was “not sure” whether vaccines caused autism could
be categorized as believing the theory is possible since they discussed vaccines and did not rule
them out as a potential cause.
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Reliability
The author and a non-researcher1, who was unfamiliar with the goals of the study, each
coded a random selection of 10% (N=12) of the transcripts to be coded in the study in order to
determine intercoder reliability. The non-researcher coder was trained by reviewing the
codebook (Appendix A) and the coding sheet (Appendix B) with the author/researcher to ensure
that both understood what they were coding in the stories. Cohen’s kappa was used to assess
reliability for each variable coded. Kappa values ranged from .769 to 1, with an average of .959,
indicating excellent agreement (Neuendorf, 2002; Banerjee, Capozzoli, McSweeney & Sinha,
1999). Table 3.1 provides the kappa values for each variable except for those that had a kappa
value of 1, indicating perfect agreement. There were a total of 98 variables coded.
Table 3.1. Intercoder Reliability: Variables and corresponding kappa values (excluding variables
with kappa value of 1)
Variable
Placement
Causes: focus of the story
Vaccines (cause)
Rates/Prevalence: focus of the story
Rates “increasing”
“Public Health Concern”
First person interviewed (category)
Second person interviewed (category)
Second person interviewed and their beliefs
regarding vaccines ( “pro-link” or “anti-link”)
Third person interviewed (category)
Third person interviewed and their beliefs
regarding vaccines (“pro-link” or “anti-link”)
Fourth person interviewed (category)
Fifth person interviewed (category)

1

Kappa value
.882
.838
.769
.867
.871
.800
.874
.875
.888
.883
.891
.860
.855

“non-researcher” is defined as someone who does not conduct quantitative or qualitative research to test
hypotheses or answer research questions. In this case, the coder was an attorney and had no professional experience
in conducting research, communication or other types.
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Data Analysis
Frequency tables were used to provide descriptors for each variable at the nominal level:
determining the salience of autism-related stories (placement and length of story), understanding
which theories and research have received the most coverage regarding the causes of autism and
how they are framed, understanding which prevalence data and numbers have been used by the
media to describe the number of people with autism and how these numbers have been framed,
and understanding who the media interviews the most regarding autism-related stories. Chisquare analyses were employed to determine if significant differences existed between the
networks’ coverage in the frequency of autism-related stories, vaccine-related autism stories, and
the framing of vaccines as a likely cause. A one-way analysis of variance (ANOVA) was used to
determine if significant differences existed between the networks in terms of length of autism
stories. The next chapter focuses on the results of this data analysis.
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CHAPTER 4
RESULTS
The sample included 121 transcripts of autism stories appearing in evening television
news broadcasts between January 1994 to April 2010. Of these, 36.4% appeared on ABC
(N=44), 32.2% appeared on CBS (N=39), and 31.4% appeared on NBC (N=38). The median
length of story ranged from 2:01 to 2:30 minutes. More than three-fourths of the autism-related
stories that were coded had a prominent placement in the newscast: 8.3% were the lead story
(N=10); 42.1% were before the first commercial or lead story after the first commercial (N=51);
and, 25.6% were the lead story after any other commercial than the first story (N=31).
Prominence of Autism-related Stories
The first set of research questions were designed to capture the salience of autism related
news stories. Research question 1a addressed whether the frequency of autism-related television
evening news stories increased, decreased, or remained stable during the study period. As shown
in Figure 4.1, the number of autism stories increased from 2001 (N=2) to 2002 (N=12). The
number of autism stories also increased from 2006 (N=14) to 2007 (N=25), the most of all the
years in the analysis (20.7%). There was a slight decrease from 2007 (N=25) to 2008 (N=20) as
well as from 2008 (N=2008) to 2009 (N=17). No stories focusing on autism appeared on any of
the major television networks evening news broadcasts in 1994, 1995, and 1998. Television
evening news coverage of autism-related issues increased yearly starting in 2004 until peaking in
2007. Since 2005, between 12 and 25 autism-related news stories have appeared on television
evening news programs per year.
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Figure 4.1. Frequency of autism-related stories by year.
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For comparison to other content analyses of autism media coverage of the vaccine/autism
controversy, an analysis was run to establish whether stories mentioning or focusing on vaccines
as a cause of autism by year, increased, decreased, or remained relatively stable during the study
period. Figure 4.2 shows there was an increase from 2001(N=1) to 2002 (N=5) (similar to the
overall increase in autism-related stories). There was also an increase from 2004 (N=4) to 2005
(N=7); a decrease from 2005 (N=7) to 2006 (N=2), followed by an increase in 2007 (N=7).
Stories mentioning or focusing on vaccines as a potential cause of autism peaked in 2008
(N=10).
Figure 4.2. Frequency of autism stories mentioning or focusing on vaccines by year.
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Research question 1b addressed whether the placement of autism-related television
evening news stories had become more prominent, less prominent, or remained relatively the
same during the study period. As seen in Table 4.1, more than three-fourths of autism-related
stories were either a lead story (N=10, 8.3%), occurred before the first commercial or were the
lead story after the first commercial break (N=51, 42.1%), or were the lead story after any other
commercial break (N=31, 25.6%). Only 29 stories (24%) did not have a prominent placement.
Table 4.1. Frequency of autism-related story by placement in broadcast.
Placement
Lead story
Before first commercial or lead story after first commercial
Lead story after any other commercial
Last story
Other (defined as placement anywhere not included above)

Frequency
10
51
31
10
19

Percentage
8.3%
42.1%
25.6%
8.3%
15.7%

As the number of autism-related stories increased, the placement has remained relatively
the same; however, there are some notable points in time where placement did change. From
1994 to 2006, there were no lead stories featuring autism. In 2007, autism-related stories were
the lead story 7 times. That number has declined since that time, with only 3 additional lead
news stories on autism. The majority of autism-related stories between 1994 and 2010 appeared
before the first commercial break or were the lead story immediately after the break. From 1994
to 2004, autism-related stories presented before the first commercial break or lead story after the
first commercial break ranged between 0 to 2, but in 2005, that number jumped to 7. From 2007
to 2009, autism-related stories were presented before the first commercial break or were the lead
story after the first commercial break in at least 10 broadcasts per year. Research question 1c
addressed whether there were significant differences between the networks regarding length of
story as well as placement. Analysis using a one way analysis of variance (ANOVA) revealed no
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significant differences between the networks regarding length of story, F(2, 118) = .173, p =
.842. Analysis using a chi-square test revealed no significant difference between the networks
regarding story placement, X2 (8) = 4.90; p=.768.
Autism Causes and Risk Factors
The second set of research questions was designed to understand which potential causes
of autism have received the most coverage and how they were framed. Research question 2a
addressed the frequency that autism-related stories included a discussion of potential causes. Out
of 121 stories, 61.2% (N=74) addressed causes. Of these stories that included causes, 78.4%
(N=58) focused on causes as the main topic, where as 21.6% (N=16) just mentioned the causes
within the story, but cause(s) was not the main focus of the story.
Research question 2b asked what causes were addressed the most frequently in autismrelated stories. As shown in Table 4.2, when causes were included in autism-related stories
(N=74), 68.9% (N=51) discussed vaccines, the most discussed of all causes. Genetics or genes
was included in 35.1% (N=26) of the stories and environment was discussed as a potential cause
in 21.6% of the stories (N=16). No other cause was mentioned in more than 10% of the stories
that mentioned causes. It should be noted that out of all autism-related stories (N=121), 42.1%
(N=51) either mentioned or focused on vaccines as a cause for autism.
Table 4.2. Frequency that specific causes were identified within stories that identified potential
causes of autism.
Cause
Vaccines
Genetics/Genes
Environment
Brain irregularities
Medications
Prenatal Exposures to Viruses
Other

Frequency
51
26
16
4
0
0
6

Percentage of stories
that mentioned a cause
68.9%
35.1%
21.6%
5.4%
0
0
8.1 %
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Research question 2c asked when an autism-related story includes one cause, how often
are other causes mentioned? Out of 121 stories focusing on autism, 51 discuss vaccines as a
potential cause. Out of 51 stories discussing vaccines as a potential cause, 80.4% (N=41) of
stories did not mention any other causes; 13.7% (N=7) mentioned one other cause; 5.9% (N=3)
mentioned two other causes. When genes were mentioned as a potential cause (N=26), genes was
included by itself with no other causes in 53.8% of stories (N=14), with one other cause in 38.5%
of stories (N=10), and with two other causes in 7.7% of stories (N=2). The two causes most
frequently discussed in the same news story were genes and environment (N=11). Genes and
vaccines (N=9) and vaccines and environment (N=8) were also mentioned together.
Research question 2d addressed how each cause was most frequently presented: as likely,
unlikely, or not enough is known to determine if it is a cause. As shown in Table 4.3, when
vaccines were included in a story (N=51), they were framed as unlikely to be a cause of autism in
54.9% (N=28) of the stories, likely to be a cause of autism in 19.6% (N=10) of the stories, and
that there is not enough known to determine whether or not it is a cause in 25.5% (N=13) of the
stories. These results show that while most stories framed vaccines as unlikely to cause autism,
nearly half of the stories that mentioned vaccines suggested that they could potentially be a cause
or that more information is needed. When genes were included in a story (N=26), the majority of
stories (80.8%) framed genes as a likely cause of autism, while no stories presented it as
unlikely. This is consistent with the scientific community, where most agree that genes are a
likely cause of autism (NIH, 2009). That 75% (N=12) of the stories about environmental causes
(N= 16) of autism suggest that more information is needed is not surprising, given that while
scientists agree that there are environmental factors that contributes to causing autism, there
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needs to be more research to determine which environmental factors may cause autism, making
it a current research priority.
Table 4.3. Frequency that when a cause is included in a story, it is presented as a likely cause, an
unlikely cause, or that more information is needed to determine if it is a cause of autism.
(Percentages within stories about each cause).
Vaccines
Story suggests the cause is unlikely
Story suggests the cause is likely
Story suggests not enough is known
Genetics/Genes
Story suggests the cause is unlikely
Story suggests the cause is likely
Story suggests not enough is known
Environment
Story suggests the cause is unlikely
Story suggests the cause is likely
Story suggests not enough is known
Brain
Story suggests the cause is unlikely
Story suggests the cause is likely
Story suggests not enough is known
Other
Story suggests the cause is unlikely
Story suggests the cause is likely
Story suggests not enough is known

Frequency
28
10
13

Percentage
54.9%
19.6
25.5

0
21
5

0
80.8
19.2

0
4
12

0
25.0
75.0

0
3
1

0
75.0
25.0

0
0
6

0
0
100.0

Research question 2e asked if the framing of vaccines as a likely cause of autism
increased, decreased, or remained relatively stable during the study period. As seen in figure 4.3,
2004 saw an increase in stories suggesting vaccines are a likely cause of autism (2003: N= 1;
2004: N= 4), whereas no stories suggested that it was unlikely that vaccines cause autism or that
not enough is known or is it inconclusive whether vaccines cause autism. In 2005, there was an
increase in stories suggesting it was unlikely vaccines cause autism, whereas no stories presented
the cause as likely, and a few (N=3) suggested that not enough is known or is inconclusive. From
2007 to 2010, there was a marked increase in the number of stories suggesting that it is unlikely
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that vaccines cause autism (2007: N= 5; 2008: N=6; 2009: N=6; 2010: N=4), whereas the number
of stories suggesting the cause was likely dropped to zero, with the exception of 2008 (N=3) and
the number of stories suggesting that not enough is known or it is inconclusive about whether
vaccines cause autism remained relatively the same (2007: N=2; 2008: N=1; 2009: N=1; 2010
N=0).
Figure 4.3. Frequency that stories framed vaccines as a likely, unlikely or that not enough is
known to determine it as a cause of autism by year.
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Research question 2f asked whether the frequency of vaccine–related autism stories
varied significantly between the networks (ABC, CBS, or NBC) during the study period.
Analysis using a chi-square test revealed no significant difference in the frequency of vaccinerelated autism stories between the networks, X2 (2) = 2.08; p=.353. CBS either mentioned or
focused on vaccines as a potential cause of autism (framed as likely, unlikely or inconclusive) 21
times, NBC 19 times and ABC 11 times. Research question 2g asked whether there was a
significant difference in the frequency that the networks (ABC, CBS, or NBC) framed vaccines
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as a likely of autism. For the purpose of this analysis the number of stories indicating vaccines
were likely a cause of autism were compared to those that presented an alternative framing (e.g.,
as either unlikely to cause autism or that more information is needed to determine if it is a
cause). Analysis using a chi-square test revealed a significant difference in the frequency that the
networks framed vaccines as a likely cause of autism, X2 (2) = 8.195; p=.017. In the stories that
discussed vaccines as a cause, ABC never suggested the cause was likely, CBS suggested the
cause was likely in 28.6% (N=6) of its stories, and NBC suggested the cause was likely in 21.1%
(N=4) of its stories. ABC suggested vaccines was unlikely to be a cause of autism or more
information was needed to determine if vaccines are a cause in all (N=11) of its stories about
vaccines, CBS suggested the cause was unlikely or more information was needed in 71.4%
(N=15) of its stories about vaccines, and NBC suggested the cause was unlikely or more
information was needed in 76.4% (N=15) of its stories about vaccines. The results show that of
all the networks, CBS suggested that vaccines were likely a cause of autism more often than the
others and ABC the least often.
Autism Prevalence and Rates
The third set of research questions was designed to examine what prevalence numbers,
rates, or statistics the media used in describing the number of people with autism, when they
were used, and how they were framed. Out of 121 stories, 46.3% (N=56) included statistics or
estimates about the number of people with autism or the prevalence of autism. Research question
3a addressed what rates or statistics the media used in describing the number of people with
autism each year. As seen in Figure 4.4, in stories that presented rates or prevalence of autism, 1
in 166 was presented 12 times during the study period, and was first cited in 2005; 1 in 150 was
presented 18 times during the study period, and was first cited in 2007, when the data was
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released; 1 in 90/91 was only cited 2 times, in 2009 when the data was released; 1 in 110 was not
cited at all despite its release in 2009 as a follow up to the 1 in 150 prevalence rate. The results
show that out of 56 stories including rates or prevalence of autism, 83.9% (N=47) used “other”
rates or numbers differing from the numbers that were coded, most notably in 2007, when CDC
released the 1 in 150 prevalence estimates for the U.S. and 2009, when HRSA and CDC released
additional prevalence estimates.
Figure 4.4. Frequency of prevalence, rates of autism included in autism-related stories, per year.
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Research question 3b addressed whether the prevalence of autism was framed as increasing;
33.1% (N=40) of stories characterized autism as increasing. As shown in Figure 4.5, 1997 was
the first year autism was characterized as increasing. 2007 had the highest number of stories
characterizing autism as increasing (N=9), the year that CDC released its 1 in 150 prevalence
data. Prior to that time, 2002 and 2004 had 4 stories each characterizing autism as increasing and
2005 and 2006 had 5 stories each characterizing autism as increasing. Analysis using a chisquare test revealed no significant difference in the frequency that the networks framed autism as
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increasing, X2 (2) = 2.05; p=.359. Of the 40 stories that framed autism as increasing, 15 appeared
on CBS, 14 on NBC, and 11 on ABC.
Figure 4.5. Frequency of stories characterizing autism as increasing by year.
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Research question 3c addressed whether autism was framed as an epidemic; 9.1% (N=11)
of stories characterized autism as an epidemic. As shown in Figure 4.6, 2002 was the first year
autism was characterized as an epidemic (N=1). The number of stories framing autism as an
epidemic increased in 2004 (N=2), peaked in 2005 (N=4), and slightly decreased in 2006 (N=3).
Only 1 story characterized autism as an epidemic in 2007, the year CDC released its 1 in 150
prevalence data. Analysis using a chi-square test revealed no significant difference in the
frequency that the networks framed autism as an epidemic, X2 (2) = 3.26; p=.196. Of the 11
stories framing autism as an epidemic, six appeared on NBC, three on CBS, and two on ABC.
Research question 3d addressed whether autism was being framed as a public health concern;
2.5% (N=3) of stories characterized autism as a public health concern. It was characterized as a
public health concern once in 2004, once in 2007 (the year CDC called autism a “public health
concern”), and once in 2009.
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Figure 4.6. Frequency of stories characterizing autism as an epidemic by year.
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Sources
The fourth set of research questions was designed to examine who the media interviews
in news stories about autism. Research question 4a addressed what category of people were most
frequently interviewed in autism-related television evening news stories. Those individuals who
were interviewed could be coded into multiple categories. Out of all 121 stories, there were a
total of 301 people interviewed. A separate data set was created so that each person interviewed
could be treated as a separate case for the analysis in this section. As seen in Figure 4.7, 34.2%
(N=103) of individuals interviewed were identified as a parent or family member of a person
with autism; 12.3% (N=37) of individuals interviewed were identified as a researcher or
representative from a university; 6.3% (N=19) of individuals interviewed were identified as a
medical expert affiliated with a hospital; 5.6% (N=17) of individuals interviewed were identified
as a government health official; 5.3% (N=16) of individuals interviewed were identified as a
person with autism; 3.3% (N=10) of individuals interviewed were identified as a leader of an
advocacy or non-profit organization not labeled as a medical expert; 2.7% (N=8) of individuals
interviewed were identified as a medical expert affiliated with an autism advocacy organization;
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2% (N=6) of individuals interviewed were identified as a health professional representing a
health professional organization; 1% (N=3) of individuals interviewed were identified as
celebrities; and, 28.2% (N=85) individuals were identified as “other,” indicating the person did
not fit into any of the given categories. Of the 85 individuals interviewed that were identified as
“other,” a few (N=4) were parents of children who refused to vaccinate their children; a few
(N=4) were identified as members of congress; several (N=5) were identified as being a part of
the developmental disabilities research and treatment center called the Kennedy Krieger
Institute; several (N=6) were medical editors for the networks and were labeled as having
medical degrees; and, several (N=11) were identified as health professionals, but with no
affiliation to a health professional organization, advocacy organization, or with the government.
The majority of the rest of the sources that were coded as “other” were labeled with first and last
names and no other identifying information in the transcript, either by their name or by their own
words.
Research question 4b addressed who most frequently was interviewed in stories that
mentioned or focused on potential causes of autism. Out of 121 stories, 61.2% (N=74) addressed
causes. There were a total 195 people interviewed in these 74 stories. As seen in Figure 4.8, of
the 195 interviews, 34.3% (N= 67) individuals interviewed were identified as a parent or family
member of a person with autism; 14.4% (N=28) individuals were identified as a researcher or
representative from a university; 8.2% (N=16) individuals were identified as a medical expert
affiliated with a hospital; 7.7% (N=15) individuals were identified as a government health
official; 3.6% (N=7) individuals were identified as a leader of an advocacy or non-profit
organization, not labeled as a medical expert; 2.6% (N=5) of the individuals were identified as a
medical expert affiliated with an autism advocacy organization; 2.6% (N=5) of the individuals

65
were identified as a medical expert affiliated with a health professional organization; 1% (N=2)
of the individuals were identified as a celebrity; and, 26.7% (N=52) of the individuals were
identified as “other,” indicating the person did not fit into any of the given categories. No stories
about causes of autism included interviews with individuals who were identified as a person with
autism.
Figure 4.7. Frequency of individuals interviewed in all autism-related stories.
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Figure 4.8. Frequency of individuals interviewed about causes.
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Research question 4c addressed who most frequently was interviewed about vaccines.
Out of 121 stories, 42 focused on vaccines. There were a total of 117 people interviewed in these
42 stories. As seen in Figure 4.9, of these 117 interviews, 28.2% (N=33) of the individuals were
identified as a parent or family member of a person with autism; 11.9% (N=14) of individuals
were identified as a researcher or representative from a university; 11.1% (N=13) of individuals
were identified as a government health official; 7.6% (N=9) of individuals were identified as a
medical expert affiliated with a hospital; 3.4% (N=4) of individuals were identified as a medical
expert affiliated with a health professional organization; 2.6% (N=3) of individuals were
identified as a leader of an advocacy or non-profit organization, not labeled as a medical expert;
1.7% (N=2) of individuals were identified as a medical expert affiliated with an autism advocacy
organization; 1.7% (N=2) individuals were identified as a celebrity; and, 31.6% (N=37)
individuals were identified as “other,” indicating the person did not fit into any of the given
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categories. No stories focusing on vaccine as a cause of autism included interviews with
individuals who were identified as a person with autism.
Figure 4.9. Frequency of individuals interviewed about vaccines.
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Research question 4d asked, of those individuals who were interviewed about vaccines,
who most frequently presents a case for vaccines as a cause of autism (pro-link) and who most
frequently makes a case against vaccines being a cause (anti-link). Note, there were some
individuals interviewed who did not present a case for or against a cause of autism in these
stories and they were excluded in this analysis. Analysis using non parametric chi-square tests
for each interview source type revealed:
·

Parents or family members of a person with autism were significantly more likely
to present a case for vaccines as a cause of autism (pro-link) when interviewed,
X2(1) = 18.24; p=.000. Of the 29 parents or family members of a person with
autism presenting an opinion, 89.7% (N=26) were pro-link, while 10.3% (N=3)
were anti-link.

68
·

Government health officials were significantly more likely to present a case
against vaccines as a cause of autism (anti-link) when interviewed, X2(1) = 7.36;
p=.007. Of the 11 government health officials presenting an opinion, 90.9%
(N=10) were anti-link, while 9.1% (N=1) were pro-link.

·

Medical experts from hospitals were significantly more likely to present a case
against vaccines as a cause of autism (anti-link) when interviewed, X2(1) = 5.44;
p=.020. Of the 9 medical experts from hospitals presenting an opinion, 88.9%
(N=10) were anti-link, while 11.1% (N=1) were pro-link.

·

Researchers or representatives from universities were not significantly more
likely to present a case to present a case for (pro-link) or against (anti-link)
vaccines as a cause of autism when interviewed, X2(1) = 2.57; p=.109. Of the 14
researchers or representatives from universities presenting an opinion, 71.4%
(N=10) were anti-link, while 28.6% (N=4) were pro-link.

·

Leaders of advocacy or non-profit organizations (non-medical) were not
significantly likely to present either a case for (pro-link) or against (anti-link)
vaccines as a cause of autism when interviewed, X2(1) = .333; p=.564. Of the 3
leaders of advocacy or non-profit organizations (non-medical) presenting
opinions, 66.7% (N=2) were pro-link, while 33.3% (N=1) were anti-link.

·

People identified as “Other” were not significantly more likely to present either a
case for (pro-link) or against (anti-link) vaccines as a cause of autism when
interviewed, X2(1) = 2.455; p=.117. Of the 33 identified as “other” presenting
opinions, 63.6% (N=21) were pro-link, while 36.4% (N=12) were anti-link.
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·

Of the 2 interviews with medical experts from advocacy or non-profit
organizations, both presented pro-link (N=2) cases.

·

Of the 4 health professionals representing health professional organizations
presenting an opinion, all (N=4) were anti-link.

·

Of the 2 celebrities presenting an opinion, all (N=2) were pro-link.

·

No people with autism were interviewed about vaccines, therefore no opinions
about vaccines as a cause were presented.

The next chapter discusses the findings and limitations of this study as well as suggestions for
future research and conclusions.
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CHAPTER 5
DISCUSSION
The medical and scientific communities have faced significant challenges in
understanding and establishing autism as a distinct condition and its causes and risk factors. How
the public understands this condition and the research conducted thus far via media and other
sources can have public health implications, as demonstrated in Britain with the increase in
measles cases (Lewis & Speers, 2003). The increase in measles cases in Britain was a result of
the decline of measles, mumps, and rubella (MMR) vaccinations, which has been attributed to
the media’s coverage of the debate over whether the MMR vaccine causes autism (Lewis &
Speers, 2003). To understand the U.S. media’s contribution to the public discourse on autism,
this study analyzed television news media coverage using agenda-setting theory and media
framing concept perspective. Agenda-setting theory provided the framework to examine the
prominence of autism in evening news broadcasts and media framing scholarship provided the
framework to examine how these evening news broadcasts characterize certain aspects
(prevalence and causes) of autism and make them more salient. A content analysis was
conducted of autism-related stories featured in national television evening news broadcasts airing
on ABC, CBS, and NBC from 1994, when autism was first recognized as a spectrum disorder in
the D SM -IV, through April 2010, the time of this study. The data provided a descriptive look at
how television evening news broadcasts feature autism in terms of salience and framing of
causes and prevalence.
Prominence of Autism-related Stories
This study captured the prominence of autism-related news stories by examining the
frequency of stories during the study period, the placement of stories during the study period,
and the length of stories during the study period. According to the results, autism-related stories
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have increased over time and have maintained prominent positions within television evening
news broadcasts. In 2007 the numbers of autism related stories peaked and achieved the most
prominence by serving as the lead story in several broadcasts. Length of autism-related stories
remained the same, but the median of 2:01 to 2:30 minutes is more than the average of most
stories (Watkins, 2001). The analysis suggests that autism has become more salient in television
evening news over time. There were a total of 121 stories focusing on autism from 1994 through
April 2010. No television evening news stories focused on autism in 1994, 1995, and 1998. The
frequency of stories quadrupled from 2001 (N=2) to 2002 (N=12) and nearly doubled from 2006
(N=14) to 2007 (N=25). The number of autism-related stories in evening news broadcasts peaked
in 2007, the year CDC released its first multi-site autism spectrum disorder (ASD) prevalence
data, stating that 1 in 150 eight-year-olds had an ASD. This suggests that the release of the
prevalence data may have elevated autism as an important issue in the eyes of the media and thus
for the public.
Given the controversial nature of the hypothesis that vaccines cause autism, the
frequency of stories either mentioning or focusing on vaccines during the study period was
examined for spikes in coverage as well. The results revealed no or low coverage from 1998 to
2000; increases in coverage from 2001 to 2002 and from 2004 to 2005; a decrease from 2005 to
2006, followed by an increase in 2007. Stories mentioning or focusing on vaccines as a potential
cause of autism peaked in 2008. Future qualitative analysis studies of these stories could reveal
exactly what news items caused the spike in terms of vaccines and autism, but there are a couple
of points in time worthy of mentioning based on events written about in this study’s literature
review. In 1998, the Wakefield et al. (1998) study was published in The Lancet, and it did not
seem to garner any coverage in U.S. television evening news that year. In 1999, the U.S. Food
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and Drug Administration (FDA) recommended that thimerosal be removed from routine infant
vaccines in the U.S., but it did not seem to garner much coverage in U.S. television evening news
that year. In 2001, the Institute of Medicine issued its first report on the hypothesized link
between the MMR vaccine and autism and it did not seem to generate much coverage in U.S.
television evening news that year. In Britain, Lewis and Speers (2003) observed that the MMR
vaccine became controversial between January and September of 2002 because a BBC television
program, Panorama, aired a broadcast titled “How safe is MMR” on February 3, 2002, taking up
Wakefield’s theory regarding the MMR vaccine. Wakefield and other colleagues also prepublished a paper in Molecular Pathology that was made available when this broadcast aired.
Reporting of a measles outbreak in a middle-class London suburb also highlighted the
controversy during this period of time. Perhaps, the attention on the subject in Britain generated
coverage of the debate in the U.S. as well in 2002. Again, a thorough qualitative analysis of the
broadcast transcripts would reveal what news items garnered attention related to vaccines and
autism. In 2004, the IOM released their report stating that they had reviewed all scientific
evidence to date and rejected the causal relationship between autism and the MMR vaccine and
thimerosal-containing vaccines, which might explain the increase in coverage that year. As for
2008’s increase in coverage of vaccines and autism, there is nothing in the literature review that
points to significant events taking place; however, a qualitative analysis study of these stories
could reveal exactly what news items caused the spike in terms of vaccines and autism. Clarke’s
(2008) content analysis of U.S. and British newspapers (February 1998 to June 2006), in fact
found similar results in terms of increasing and decreasing coverage of vaccine/autism stories:
relatively low coverage of the vaccine/autism controversy from 1998 to 2000, increased attention
from 2001 to 2002, a spike in articles in 2004, and a steady decline in 2005 and 2006. This
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suggests that newspapers and evening news coverage are similar in terms of when they increased
and decreased coverage of autism stories that discuss vaccines.
Regarding placement in the broadcast, three-fourths of all autism-related stories were
either a lead story, occurred before the first commercial or were the lead story after the first
commercial, or were the lead story after any other commercials—considered prominent positions
within a television evening news broadcast according to the literature review. Over the study
period, placement remained relatively the same with the exception of two points in time. From
1994 to 2004, autism-related stories presented before the first commercial or lead story after the
first commercial ranged from 0 to 2, but in 2005, that number jumped to 7.. From 1994 to 2006,
no lead story had ever featured autism, but in 2007, autism was featured as a lead story 7 times.
CDC’s released of its 1 in 150 prevalence data that year would seem to have elevated its
importance in the eyes of the media. While the length of autism-related stories remained
relatively the same throughout the study period, the median of two to two and a half minutes was
more than the average of most stories: one-and-a-half to two minutes (Watkins, 2001) as noted in
the literature review. There were no significant differences in the frequency of autism-related
stories between the networks in terms of length of story and placement reveals that the networks
view autism’s prominence in a similar manner. For the public, they are receiving a consistent
message from the networks’ evening news coverage: it is an important issue that they should be
concerned about, especially since 2007.
This study sought to understand how through selection of news stories, the media focus
the public’s attention on some issues more than others and influence perceptions about what the
most important issues are using agenda-setting theory as a framework. This study did not
compare autism with other issues during the study period to determine its salience relative to
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other topics, but the increase in the number of stories and increase in the number of stories with
prominent position within the broadcast indicates that autism has become more salient in
television evening news stories over time. Therefore, the media’s increasing coverage of autism
may result in the public’s perception that it is something they should think about. The secondlevel of agenda setting, attribute agenda setting, suggests that in addition to the media telling us
what to think about, they also tell us how to think about some objects. In this framework, the
results show that the frequency of all stories featuring autism that included vaccines as a cause of
autism were quite high—nearly half the time. It can be said, then, that the attribute, in this case
the potential for vaccines causing autism, is salient.
Autism Causes and Risk Factors
As noted in the literature review, scientists are not certain about what causes autism, but
agree it’s likely that both genetics and environment play a role (NIH, 2009). Some of the most
controversial hypotheses about causes have concentrated on demonstrating a link between
vaccines and autism. Considering the media’s effect on the decline of MMR vaccines in Britain
(Lewis & Speers, 2003) and the recent survey reporting that 1 in 4 U.S. parents believe vaccines
cause autism, 81% of whom reported that they had heard or read about problems with the MMR
vaccine (Freed et al., 2010), this investigation sought to understand the media’s contribution to
the public discourse on potential causes, and how it framed them, especially vaccines. This study
captured which causes of autism have received the most coverage and whether the media framed
the causes as likely or unlikely.
This study found that nearly half of the time that television evening news media report on
autism, they are associating it with vaccines. The association of autism with vaccines has the
potential of having an applicability effect. In media framing research, an applicability effect
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refers to an audience’s acceptance that two concepts are related after exposure to a media
message that suggests there is a connection between two concepts (Scheufele & Tewksbury,
2007). Future studies with media audiences could examine whether an applicability effect has
indeed occurred as a result of television evening news associating autism with vaccines. This
study also found that stories focusing on causes of autism are not mentioning other scientifically
accepted causes of autism. The data revealed that vaccines were the only cause discussed in the
overwhelming majority (80%) of stories that mentioned vaccines. The stories that frame vaccines
as either unlikely as a cause or suggest that more research is needed to determine if it is a cause
of autism should at least mention the causes that have been accepted by the scientific
community, but did not consistently do that. There was an increase after 2004 in stories
suggesting vaccines were an unlikely cause of autism, which is to be expected given the release
of the 2004 IOM report rejecting causal relationships between vaccines and autism. However,
the repetitious association between autism and vaccines, even when framed as unlikely, in
television evening news could have a potential audience applicability effect, especially when
other potential causes are not being discussed. Audience research is needed to determine whether
the public is willing to accept the causes established as more likely by the scientific community.
For the public, they are receiving a consistent message from the networks’ evening news
coverage: autism and vaccines are an important issue that they should be concerned about.
The National Institutes of Health’s (NIH) (2009) stated that it is likely that both genetics
and some environmental factor(s) play a role in causing autism. The data revealed the two causes
most frequently discussed together were genes and environment. Stories that discussed genetics
as a potential cause always presented it as likely or that more research was needed. The fact that
no story framed genetics as an unlikely cause of autism was an interesting finding when
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compared to vaccines (which were framed as a likely cause in almost half the stories) and speaks
to the controversial nature of the hypothesis that vaccines cause autism: because it is
controversial it will receive more coverage than something than is not controversial.
The analysis revealed no significant difference in the frequency of vaccine-related autism
stories between the networks. The public is receiving a consistent message from the networks’
evening news coverage: autism and vaccines are an important issue that they should be
concerned about. However, there was a significant difference in the frequency that the networks
(ABC, CBS, or NBC) framed vaccines as a likely of autism. : ABC was significantly less likely
to frame vaccines as a cause of autism (no pro-link stories appeared on the network) as compared
to CBS and NBC.
Autism Prevalence and Rates
This study also examined what prevalence numbers, rates, or statistics the media used in
describing the number of people with autism by year and how the number of people with autism
or the prevalence of autism was framed. The results showed that the majority of stories
mentioning prevalence rates cited numbers that had not been identified in the literature review.
One third of stories framed autism as increasing regardless if data were cited. Furthermore,
television evening news has not significantly contributed to the framing of autism as an
epidemic. In terms of the rates or statistics used by the media, the one in 166 prevalence data
(Fombonne, 1999) was presented 12 times during the study period; it was first cited by television
evening news in 2005 and Fombonne published the data in 1999. Another noteworthy finding
was that CDC’s one in 150 prevalence data was presented 18 times during the study period, and
was first cited in 2007, when the data were released. The Health Resources and Services
Administration (HRSA) study reporting one in 90 children had autism was included in two
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stories in 2009, the time of its release. CDC’s one in 110 prevalence data was published in 2009
after HRSA’s data release, as a follow up to the 2007 prevalence report of one in 150, but
received no coverage despite that its methods (use of clinical and education records) are more
highly regarded than those used in the HRSA study (a survey of parental reports), although they
are considered to be complimentary methods of determining the number of people with autism.
For the media, reporting a prevalence of one in 90 in October and then to turn around and report
a prevalence of one in 110, perhaps, did not make sense. It suggests that the media feel like they
have established autism as a prevalent condition and that backtracking and using the CDC’s data
would have been confusing for the public. Which prevalence data the media uses moving
forward will prove to be interesting, given that CDC and HRSA are funded to and have plans to
report on their respective studies again in two years.
The data also revealed the media’s use of “other” rates of or prevalence of autism was
quite high (i.e., prevalence rates that differed from the numbers that were coded, which were
based on published reports cited in the literature). Nearly 84% of stories mentioning prevalence
rates cited numbers that had not been identified in the literature review, some occurring after
2007 when CDC established its prevalence rate of 1 in 150. It should be noted that “other”
numbers coded included state level data (e.g., Oregon and California) and could account for the
large percentage of pieces that cite “other” prevalence rates. It also speaks to the fact that there
were no accepted prevalence rates of autism for the U.S. prior to 2007. Given the number of
“other” numbers cited after 2007, future research should consider how media interpret
prevalence data. For example, the media may be more comfortable reporting a concrete number
of people with autism (e.g., 1.2 million) versus reporting it as a one in 110 or one in 90. Future
studies should also examine autism advocacy organizations and their use of the prevalence data
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to better understand when and how these numbers have been used to draw attention to autism
issues.
This study also examined how the prevalence data or rates/estimates have been framed by
the media in terms of whether autism is increasing, an epidemic, or an urgent public health
concern. The framing of prevalence data can potentially affect government policies and for
funding autism research and services. Also, by framing it as increasing over the same years that
the number of required vaccinations has increased, then the argument for a vaccination-autism
connection may be strengthened. The data revealed that one third of stories framed autism as
increasing regardless if data were cited. Very few stories framed autism as an epidemic (most
occurring around 2006, before CDC established prevalence data) and even fewer framed autism
as a public health concern. While one third of stories framed autism as increasing, it appears that
television evening news has not significantly contributed to the framing of autism as an
epidemic. That only a couple of stories framed autism as a public health concern reveals that
television evening news has not adopted the CDC’s frame.
Sources
Because journalists tell stories primarily through those who have authoritative personal
knowledge of an event (Singer & Endreny, 1993), this study also examined who the media
interviewed in news stories about autism. Ultimately, this study found that television evening
news has framed the issue of vaccines causing autism as one where parents/family members of
children with autism believe that autism is caused by vaccines and where the medical
establishment does not believe that autism is caused by vaccines. These findings suggest that the
audience has to determine who they trust more –parents/family members of children with autism
or the government and medical community.
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Parents or family members of people with autism were most frequently interviewed in
television evening news stories about autism. In this case parents or family members of a person
with autism have authoritative personal knowledge of autism and it would serve to reason that
they are most interested in autism issues. This research revealed that when interviewed, parents
of children with autism were significantly more likely to present a case for vaccines as a cause of
autism than against it. Government health officials and medical experts from hospitals were
significantly more likely to present a case against vaccines as a cause of autism than for it.
Health professionals from health professional organizations presented a case against vaccines as
a cause of autism every time they were interviewed on the subject. This analysis reveals that
television evening news has framed this issue of vaccines causing autism as one where parents or
family members of children with autism nearly always side with the non-scientifically accepted
views that autism is caused by vaccines even though more than half of the stories frame vaccines
as an unlikely cause. It is troubling that television evening news continued to cover the
vaccine/autism issue even after the 2004 IOM report declared vaccines were not a cause of
autism, considering that the majority of the medical and scientific communities have accepted
that it is not a cause. Perhaps advocacy groups and parents of children with autism who continue
to believe that there is a link are framing their messages in a more compelling way than the
government and medical establishment. Future research should include a content analysis of
materials, Web pages, and other texts from these advocacy groups as well as a quantitative study
of the knowledge, attitudes and beliefs of parents of children with autism to determine what
messages are resonating with them. This analysis also revealed that celebrities were not often
interviewed in television evening news stories about autism. Jenny McCarthy, a celebrity and
mother of a child with autism, has become a pseudo-spokesperson for the belief that vaccines
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cause autism, yet television evening news has not featured her in this way. Future research
should include a content analysis of daytime and primetime talk shows as well as morning news
shows where celebrities are more likely to be interviewed.
Limitations of the Study
A significant limitation of this study was that it examined only the television evening
news transcripts as opposed to viewing the broadcasts in addition to the transcripts. Viewing the
broadcasts would have allowed the author to code for items featured in video footage such as
children with autism or children being vaccinated. Coding video footage would enable
researchers to better understand how broadcasts are telling the story of autism.
Another limitation of this study is its examination of one particular category of television
program: the evening news. A recent survey conducted by Pew (2008) showed that 29% of
respondents reported watching nightly network news, but that still leaves about two-thirds of
[insert who was the focus – US adults?] who are not exposed to the news messages through these
channels. That does not mean that more people were not exposed to these news messages.
Networks have multiple formats for their programming and often times repeat stories in those
various formats. Examining a network’s morning news shows, primetime news magazine shows,
and network websites could provide a more complete picture of how autism is framed and
through these networks. Also examining cable news outlets for their evening news coverage of
autism would provide a more complete picture of what message U.S. adults are receiving on
television news programs. Unfortunately, transcripts were not available for the entire study
period in order to conduct a complete content analysis. Having transcripts for cable news shows
would have enabled the study to provide a more complete picture of how television news frames
autism causes and prevalence.
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This study could have provided more descriptive information about how autism stories
were framed through a qualitative examination of stories. In addition to coding for specific items,
a thorough reading of the transcripts would have revealed, what topics related to vaccines
causing autism were garnering coverage (e.g., MMR vaccine, thimerosal, or number of
vaccines).
Finally, this study only examined the framing of two autism-related issues: causes and
prevalence. Certainly, there are other issues that warrant analysis and have received media
attention: early identification, treatment, and services. Examining these issues would have
presented a more complete picture of how the media frames autism overall.
Suggestions for Future Research
The purpose of this study was to conduct a content analysis to understand how television
news media framed autism causes and prevalence and contributed to the public discourse on
these issues from 1994, when autism was first recognized as a spectrum of disorders in the DSMIV, through April 2010. In order to provide a more complete picture of how mass media frame
autism causes and prevalence, researchers could conduct a content analysis of other television
news programming on the major networks, including their morning news shows as well as their
primetime newsmagazine shows. Doing so would allow a better comparison of how the
individual networks frame autism-related issues. A content analysis of cable news shows such as
CNN and FOX would be helpful as well. Aside from network and cable shows, researchers
should consider analyzing talk shows such as “Oprah,” “The View,” or “The Doctors,” which
feature health topics. Researchers should also conduct a content analysis of newspaper and
online coverage using a similar coding scheme to compare how other media frame these issues.
An examination of press releases released by autism advocacy organization might provide
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further understanding of how these issues are framed. A complete content analysis of all mass
media and autism advocacy organizations press releases should lay the foundation for additional
media effects research to understand, what, if any, role U.S. mass media plays in influencing
beliefs, attitudes, intentions, or behaviors of audiences in relation to autism. Conducting media
effects research with audiences using surveys, experiments, focus groups, or in-depth interviews
will also provide a true sense of whether salience has been transferred from the media to the
audience, a key component of agenda-setting theory.
Conclusion
This study advances the scholarship on agenda setting and media framing by examining
the salience of autism and related topics and addressing the news media’s portrayal of autism
causes and prevalence. The study examined the frequency of these autism-related issues from
1994 through the first few months of 2010 to better understand how television evening news
framed autism and whether the networks differed in their coverage and framing of autism. The
data show that autism has become increasingly salient in television evening news. Furthermore,
the data revealed that coverage of the vaccines/autism controversy is a salient issue in television
evening news. They also show there were no significant differences between the major networks
(ABC, CBS, and NBC) in terms of how frequently they covered autism-related stories, the
median length of those stories or the placement in the broadcast (prominent). There was a
significant difference in the frequency that the networks framed vaccines as a likely cause of
autism. The results showed that ABC never framed vaccines as a likely cause of autism in any of
their coverage of the topic during the study period as compared to CBS and NBC, whose
network news programs said it was a likely cause of autism in roughly 21 to 28% of their stories.
The majority of news stories tended to frame vaccines as an unlikely cause of autism, but they
also tended to include interviews with parents who believe that vaccines cause autism. The
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medical establishment was more likely to present the case for vaccines not causing autism, which
means that the audience has to determine who they trust more – other parents or the government
and medical community. The major networks ultimately frame autism causes and prevalence in
similar ways, providing some dominant frames for the public that should be examined in terms
of interpretation and effects. In the U.S., it is important for health communicators interested in
autism to examine the interpretation and effects of these dominant frames because of the public
health implications, especially regarding vaccines. Health communicators should use this study’s
findings and future audience effects research to develop strategies that ensure accurate
information about autism is communicated to the media and other channels that resonate with the
public.
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APPENDIX A: CONTENT ANALYSIS CODEBOOK
Television Evening News Transcripts
Content Analysis Codebook
Please read carefully all directions for coding each item. For reliability reasons, once you start
the coding process, there will be no time for more questions and discussions. Make sure to
address all your questions BEFORE you start coding. When coding, please be advised to read
the entire transcript before coding. Please write your initials in the top right hand corner of the
code sheet.
1. Transcript ID
Directions: Write down the transcript ID number, which can be found at the top right-hand
corner of first page: Vanderbilt Television News Archive.
_______________
2. Network
Directions: Look at the first page: Vanderbilt Television News Archive. Which network did the
story appear on? (Circle one)
0) ABC 1) CBS 2) NBC
3. Year of the story
Directions: Look at the first page: Vanderbilt Television News Archive and write down the
year of the story. For example, if the year is 1996, write 1996.
Year:

4. Story length/Time spent on story
Directions: Look at the first page: Vanderbilt Television News Archive Summary Look for the
text that says Program Time. To the right of Program Time, you will see the word Duration. It
will be written in minutes and seconds. Circle one below.

0). 0 to 00:30
1). 00:31 to 01:00
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2). 01:01 to 01:30
3). 01:31 to 02:00
4). 02:01 to 02:30
5). 02:31 to 03:00
6). 03:01 to 03:30
7). 03:31 to 04:00
8). 04:01 to 04:30
9). 04:31 to 05:00
10). Longer than 05:01
6. Broadcast placement
Directions: Look at the second page titled: Vanderbilt Television News Archive. At the top of
the page, the title should say “Television News Archive: Display Complete Broadcast.” Find
summary of the story about autism highlighted in yellow on the page. Is it the lead story
(defined as first story); Before the first commercial or lead story (first story) after the first
commercial; lead story (first story) after any other commercial; last story; or other (defined as
placement anywhere not included in the above places). Please circle one:
Placement in broadcast:
0). Lead story (defined as first story)
1). Before the first commercial or lead story (first story) after the first commercial
2). lead story (first story) after any other commercial
3). Last story
4). other (defined as placement anywhere not included in the above places)
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7. Topics Covered in Autism Story: Cause(s)
Directions: Following the “Vanderbilt Television News Archive Display Complete Broadcast”
pages, you will find a transcript of a news story. Read the transcript. Does the story discuss or
mention causes, risk factors, or potential causes or risk factors for autism?
Circle 0). No

or

1). Yes

Note: If 1) Yes is circled, please continue with Question 6a. Otherwise, skip to Question 7.
6a. Is the main focus of the story about causes, risk factors, or potential causes or risk
factors for autism? Or does it mention causes, risk factors, or potential causes or risk
factors for autism?
Directions: Circle one.
0). Causes/risk factors for autism were mentioned in the story, but not the main focus.
This is defined as not being the main focus of the story, but mentioned somewhere within the
story.
1). Causes/risk factors for autism were the main focus of the story
This is defined as being discussed throughout the story and is the main focus and point of the
story.

6b. Specify whether each cause or risk factor of autism was not included, mentioned, or was the
primary focus of the story.
Then, if the cause or risk factor of autism was either mentioned or was the primary focus of the
story, indicate whether story suggests that it is likely, unlikely, or inconclusive as a cause or risk
factor for autism support it as a cause.
Directions: For each cause or risk factor circle
0) not included; 1) mentioned; or 2) primary focus of the story
For each cause or risk factor where 1) mentioned or 2) primary focus of the story is
circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
This is defined as the story suggesting that the cause or risk factor is improbable, not
plausible, disproved, or unsupported by evidence, science or the majority of scientists or
unsupported by the medical community or the majority of doctors.
1) story suggests that the cause or risk factor is likely
This is defined as the story suggesting that the cause or risk factor is probable, plausible,
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proven, or supported by evidence, science or the majority of scientists or supported by
the medical community or the majority of doctors.
2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
This is defined as the story suggesting that not enough is known yet to consider
whether it is a cause or risk factor for autism.
A). Genetics or genes:
Genes or genetic causes may include the words family history or genes from mother or father.
This could also include the words twins or siblings. This could also include “risk” genes or
genes that have been identified by scientists as increasing the risk for autism.
0) not included; 1) mentioned; or 2) primary focus of the story
If 1) mentioned or 2) primary focus of the story is circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
1) story suggests that the cause or risk factor is likely
2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
B). Brain/Neurological Irregularities:
This is defined as irregularities in regions of the brain as a cause of autism. This may also
include abnormal levels of serotonin or other neurotransmitters as a cause of autism.
0) not included; 1) mentioned; or 2) primary focus of the story
If 1) mentioned or 2) primary focus of the story is circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
1) story suggests that the cause or risk factor is likely
2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
C). Prenatal Exposure to Viruses:
This is defined as prenatal exposure to viruses as a cause of autism. Some viruses that may be
mentioned include cytomegalovirus or CMV and rubella.
0) not included; 1) mentioned; or 2) primary focus of the story
If 1) mentioned or 2) primary focus of the story is circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
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1) story suggests that the cause or risk factor is likely
2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
D). Medications:
This may include medications such as, but not limited to, thalidomide, valproic acid, and
misoprostol.
0) not included; 1) mentioned; or 2) primary focus of the story
If 1) mentioned or 2) primary focus of the story is circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
1) story suggests that the cause or risk factor is likely
2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
E). Vaccines:
This includes vaccines, such as, but not limited to, the vaccine for Measles, Mumps, and
Rubella or MMR; thimerosal, a preservative in vaccines; and/or the number of vaccines as a
cause of autism.
0) not included; 1) mentioned; or 2) primary focus of the story
If 1) mentioned or 2) primary focus of the story is circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
1) story suggests that the cause or risk factor is likely
2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
F). Environment:
This may include something in the environment can cause autism. This includes using the word
“environmental” or “environment” and/or toxins, chemicals, pollutants or pesticides.
0) not included; 1) mentioned; or 2) primary focus of the story
If 1) mentioned or 2) primary focus of the story is circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
1) story suggests that the cause or risk factor is likely
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2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
G). Other:
Other is defined as a cause of autism not on this list.
0) not included; 1) mentioned; or 2) primary focus of the story
If you circled other, please write the cause in this space:
_____________________________________
If 1) mentioned or 2) primary focus of the story is circled, please circle one:
0) story suggests that the cause or risk factor is unlikely
1) story suggests that the cause or risk factor is likely
2) story suggests that not enough is known or it is inconclusive as a cause or risk factor
7. Topics Covered in Segment on Autism: Estimates/Prevalence
Directions: Does the segment present statistics or estimates about the number of people with
autism or the prevalence of autism? Prevalence is a measure of the number of cases of a disease
or condition in a defined group of people over a defined period of time and is usually given in
this manner 1 in 10 people have xxxx condition.
Circle one
0). No
or 1). Yes
Note: If 1) Yes is circled, please continue with Question 7a. Otherwise, skip to Question 8.
7a. How many statistics or estimates of the number of people with autism or prevalence
rates are mentioned in the story?
Directions: Write how many different statistics or estimates of the number of people with
autism or the prevalence rates of autism are mentioned in the story (1, 2, 3, 4….) below.
_________________
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7b. Is the main focus of the story about data presenting statistics/estimates or prevalence
of autism? Or does it just mention the data?
Directions: Circle one answer.
0). Statistics/estimates or prevalence of autism is mentioned in the story, but not the main
focus.
This is defined as not being included in the leading paragraph or sentences/or in the headline,
but mentioned somewhere else in the story.
1). Statistics/estimates or prevalence of autism is the main focus of the story
This is defined as being discussed in the leading paragraph or sentences and/or in the headline
of the transcript and may include the words “new data” or “new numbers.”
7c. According to the news story, what is the prevalence of autism or what is the statistic or
estimate given regarding the number of people with autism?
Directions: Circle the statistic/estimate or prevalence numbers provided by the news story.
Please circle or write in the exact number that appears in the story. You do not need to make
any calculations.

1. 4.5 per 10,000
2. 67 per 10,000
3. 60 per 10,000
4. 1 in 166
5. 1 in 150
6. 1 in 90 or 1 in 91
7. 1 in 110
8. 1% or 1 percent
9. other: please enter number mentioned_______________
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7d. Does the story indicate whether the autism rates are increasing or growing?
Directions: Does the story indicate whether the rates of people with autism are increasing or
growing? Circle
0). No

or

1). Yes

8. Is autism identified as an “epidemic” in the news story?
Directions: Is autism identified as an “epidemic”? [story uses this word specifically with regard
to autism]. Circle
0). No

or

1). Yes

9. Is autism identified as an “urgent public health concern” or a “public health concern” or a
“public health problem”?
Directions: Is autism identified as an “urgent public health concern” or a “public health
concern” or a “public health problem” or a “public health danger” or a “public health
concern”? [story uses one of these phrases with regard to autism]. Please circle
0). No

or

1). Yes

10. Was anyone interviewed for the segment?
Directions: Is anyone interviewed for the segment? Circle
0) No

or

1). Yes

Note: If 1) Yes is circled, please complete Question 10(a) for each different person who is
interviewed. If not, the coding for this transcript is complete
10a. Who is interviewed for the segment? Person 1.
Directions:
Person 1: This refers to the first person interviewed. Circle all that apply. For example, if the
person interviewed is a parent of a child with autism and is identified as associated with an
advocacy organization, circle both. A person must be actually interviewed and speaking, not
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just shown.
1. Government Medical/Scientific Expert
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist
who is identified as currently a part of state government or national government agency such as
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH),
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services
(HHS), or the U.S. Food and Drug Administration (FDA).
2. Medical Expert from a Hospital
A medical/scientific expert from a hospital could be a doctor or a nurse or another health
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a
hospital.
3. Medical Expert from an autism advocacy organization
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of
America. The expert is identified with an autism advocacy organization.
4. Medical Expert from a health care professional organization
A medical/scientific expert from a health care professional organization is defined as a doctor,
nurse, therapist, psychologist from an organization such as the American Academy of
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing.
The expert is identified with a health care professional organization.
5. Person with autism
6. Parents of or family member of a person with autism
7. Celebrity
A celebrity is defined as a person who is identified as an entertainer or in the entertainment
industry such as an actress/actress, singer, reality television star, etc…This also may include
professional athletes such as a basketball or football player. If a celebrity is interviewed, please
list that person’s name on the line below:
_____________________________
8. Leader or someone associated with an advocacy organization.
This is defined as anyone associated with an advocacy organization who is not explicitly
defined as a medical/scientific expert who works at an advocacy organization such as Autism
Speaks, Cure Autism Now, Autism Society of America, etc…
9. Other
Please list any other identifying information for the first person interviewed that do(es) not fit
into a category from above:
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____________________________________________________

Note: If another person is interviewed, please proceed to question 10(b). If not, please proceed
to question 11.
10b. Who is interviewed for the segment? Person 2.
Directions:
Person 2: This refers to the second person interviewed. Circle all that apply. For example, If
the person interviewed is a parent of a child with autism and is identified as associated with an
advocacy organization, circle both. A person must be actually interviewed and speaking, not
just shown.
1. Government Medical/Scientific Expert
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist
who is identified as currently a part of state government or national government agency such as
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH),
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services
(HHS), or the U.S. Food and Drug Administration (FDA).
2. Medical Expert from a Hospital
A medical/scientific expert from a hospital could be a doctor or a nurse or another health
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a
hospital.
3. Medical Expert from an autism advocacy organization
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of
America. The expert is identified with an autism advocacy organization.
4. Medical Expert from a health care professional organization
A medical/scientific expert from a health care professional organization is defined as a doctor,
nurse, therapist, psychologist from an organization such as the American Academy of
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing.
The expert is identified with a health care professional organization.
5. Person with autism
6. Parents of or family member of a person with autism
7. Celebrity
A celebrity is defined as a person who is identified as an entertainer or in the entertainment
industry such as an actress/actress, singer, reality television star, etc…This also may include
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professional athletes such as a basketball or football player. If a celebrity is interviewed, please
list that person’s name on the line below:
_____________________________
8. Leader or someone associated with an advocacy organization.
This is defined as anyone associated with an advocacy organization who is not explicitly
defined as a medical/scientific expert who works at an advocacy organization such as Autism
Speaks, Cure Autism Now, Autism Society of America, etc…
9. Other
Please list any other identifying information for the first person interviewed that do(es) not fit
into a category from above:
____________________________________________________

Note: If another person is interviewed, please proceed to question 10(c). If not, please proceed
to question 11.
10c. Who is interviewed for the segment? Person 3.
Directions:
Person 3: This refers to the third person interviewed. Circle all that apply. For example, if the
person interviewed is a parent of a child with autism and is identified as associated with an
advocacy organization, circle both. A person must be actually interviewed and speaking, not
just shown.
1. Government Medical/Scientific Expert
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist
who is identified as currently a part of state government or national government agency such as
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH),
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services
(HHS), or the U.S. Food and Drug Administration (FDA).
2. Medical Expert from a Hospital
A medical/scientific expert from a hospital could be a doctor or a nurse or another health
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a
hospital.
3. Medical Expert from an autism advocacy organization
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of
America. The expert is identified with an autism advocacy organization.
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4. Medical Expert from a health care professional organization
A medical/scientific expert from a health care professional organization is defined as a doctor,
nurse, therapist, psychologist from an organization such as the American Academy of
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing.
The expert is identified with a health care professional organization
5. Person with autism
6. Parents of or family member of a person with autism
7. Celebrity
A celebrity is defined as a person who is identified as an entertainer or in the entertainment
industry such as an actress/actress, singer, reality television star, etc…This also may include
professional athletes such as a basketball or football player. If a celebrity is interviewed, please
list that person’s name on the line below:
_____________________________
8. Leader or someone associated with an advocacy organization.
This is defined as anyone associated with an advocacy organization who is not explicitly
defined as a medical/scientific expert who works at an advocacy organization such as
Autism Speaks, Cure Autism Now, Autism Society of America, etc…
9. Other
Please list any other identifying information for the first person interviewed that do(es)
not fit into a category from above:
____________________________________________________

Note: If another person is interviewed, please proceed to question 10(d). If not, please proceed
to question 11.
10d. Who is interviewed for the segment? Person 4.
Directions:
Person 4: This refers to the fourth person interviewed. Circle all that apply. For example, If the
person interviewed is a parent of a child with autism and is identified as associated with an
advocacy organization, circle both. A person must be actually interviewed and speaking, not
just shown.
1. Government Medical/Scientific Expert
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist
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who is identified as currently a part of state government or national government agency such as
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH),
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services
(HHS), or the U.S. Food and Drug Administration (FDA).
2. Medical Expert from a Hospital
A medical/scientific expert from a hospital could be a doctor or a nurse or another health
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a
hospital.
3. Medical Expert from an autism advocacy organization
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of
America. The expert is identified with an autism advocacy organization
4. Medical Expert from a health care professional organization
A medical/scientific expert from a health care professional organization is defined as a doctor,
nurse, therapist, psychologist from an organization such as the American Academy of
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing.
The expert is identified with a health care professional organization
5. Person with autism
6. Parents of or family member of a person with autism
7. Celebrity
A celebrity is defined as a person who is identified as an entertainer or in the entertainment
industry such as an actress/actress, singer, reality television star, etc…This also may include
professional athletes such as a basketball or football player. If a celebrity is interviewed, please
list that person’s name on the line below:
_____________________________
8. Leader or someone associated with an advocacy organization.
This is defined as anyone associated with an advocacy organization who is not explicitly
defined as a medical/scientific expert who works at an advocacy organization such as Autism
Speaks, Cure Autism Now, Autism Society of America, etc…
9. Other
Please list any other identifying information for the first person interviewed that do(es) not fit
into a category from above:
____________________________________________________
Note: If another person is interviewed, please proceed to question 10(e). If not, please proceed
to question 11.
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10e. Who is interviewed for the segment? Person 5.
Directions:
Person 5: This refers to the fifth person interviewed. Circle all that apply. For example, If the
person interviewed is a parent of a child with autism and is identified as associated with an
advocacy organization, circle both. A person must be actually interviewed and speaking, not
just shown.
1. Government Medical/Scientific Expert
A government medical or scientific expert is defined as a doctor, epidemiologist, or scientist
who is identified as currently a part of state government or national government agency such as
the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH),
Environmental Protection Agency (EPA), the U.S. Department of Health and Human Services
(HHS), or the U.S. Food and Drug Administration (FDA).
2. Medical Expert from a Hospital
A medical/scientific expert from a hospital could be a doctor or a nurse or another health
provider such as a therapist or psychologist or psychiatrist. The expert is identified with a
hospital.
3. Medical Expert from an autism advocacy organization
A medical/scientific expert from an advocacy is defined as a doctor, nurse, epidemiologist, or
scientist from an organization such as Autism Speaks, Cure Autism Now, or Autism Society of
America. The expert is identified with an autism advocacy organization.
4. Medical Expert from a health care professional organization
A medical/scientific expert from a health care professional organization is defined as a doctor,
nurse, therapist, psychologist from an organization such as the American Academy of
Pediatrics, the American Academy of Family Physicians, or the American Academy of Nursing.
The expert is identified with a health care professional organization.
5. Person with autism
6. Parents of or family member of a person with autism
7. Celebrity
A celebrity is defined as a person who is identified as an entertainer or in the entertainment
industry such as an actress/actress, singer, reality television star, etc…This also may include
professional athletes such as a basketball or football player. If a celebrity is interviewed, please
list that person’s name on the line below:
_____________________________
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8. Leader or someone associated with an advocacy organization.
This is defined as anyone associated with an advocacy organization who is not explicitly
defined as a medical/scientific expert who works at an advocacy organization such as Autism
Speaks, Cure Autism Now, Autism Society of America, etc…
9. Other
Please list any other identifying information for the first person interviewed that do(es) not fit
into a category from above:
____________________________________________________

11. For each person interviewed, please indicate whether he/she presents a message that
suggests that there is no link between autism and vaccines (anti-link) or a message that
suggests that there is a link between autism and vaccines (pro-link)?
If the story did not include any mention of vaccines, then you are done coding this story.
Directions: For each person interviewed, were they pro-vaccine or anti-vaccine or not sure?
A). Person 1:
0). Anti-link.
This is defined as the person being interviewed indicating that vaccines do not cause autism or
that a link between autism and vaccines was considered improbable, unsupported by evidence,
or disproved.
1). Pro-link.
This is defined as the person being interviewed indicating that the theory or idea of vaccines
causing autism is possible, plausible, or probable.
2). Not sure
This is defined as the person being interviewed indicating that he/she is conflicted by the theory
or idea of vaccines causing autism.
3). N/A
This person does not discuss vaccines.
B) Person 2:
0). Anti-link.
This is defined as the person being interviewed indicating that vaccines do not cause autism or
that a link between autism and vaccines was considered improbable, unsupported by evidence,
or disproved.
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1). Pro-link.
This is defined as the person being interviewed indicating that the theory or idea of vaccines
causing autism is possible, plausible, or probable.
2). Not sure
This is defined as the person being interviewed indicating that he/she is conflicted by the theory
or idea of vaccines causing autism.
3). N/A
This person does not discuss vaccines.
C) Person 3:
0). Anti-link.
This is defined as the person being interviewed indicating that vaccines do not cause autism or
that a link between autism and vaccines was considered improbable, unsupported by evidence,
or disproved.
1). Pro-link.
This is defined as the person being interviewed indicating that the theory or idea of vaccines
causing autism is possible, plausible, or probable.
2). Not sure
This is defined as the person being interviewed indicating that he/she is conflicted by the theory
or idea of vaccines causing autism.
3) N/A
This person does not discuss vaccines.
D) Person 4:
0). Anti-link.
This is defined as the person being interviewed indicating that vaccines do not cause autism or
that a link between autism and vaccines was considered improbable, unsupported by evidence,
or disproved.
1). Pro-link.
This is defined as the person being interviewed indicating that the theory or idea of vaccines
causing autism is possible, plausible, or probable.
2). Not sure
This is defined as the person being interviewed indicating that he/she is conflicted by the theory
or idea of vaccines causing autism.
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3) N/A
This person does not discuss vaccines.
E) Person 5:
0). Anti-link.
This is defined as the person being interviewed indicating that vaccines do not cause autism or
that a link between autism and vaccines was considered improbable, unsupported by evidence,
or disproved.
1). Pro-link.
This is defined as the person being interviewed indicating that the theory or idea of vaccines
causing autism is possible, plausible, or probable.
2). Not sure
This is defined as the person being interviewed indicating that he/she is conflicted by the theory
or idea of vaccines causing autism.
3). N/A
This person does not discuss vaccines.
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APPENDIX B: CONTENT ANALYSIS CODE SHEET
1. Transcript I.D.:
5. Broadcast Placement: (Circle one)
0). Lead story (defined as first story)
___________
1). Before the first commercial or lead
story (first story) after the first commercial
2. Network: (Circle one)
0). ABC

2). lead story (first story) after any other
commercial

1). CBS
3). Last story
2). NBC
3. Year of Story:
_____________
4. Length of Story: (Circle one)

4). other (defined as placement anywhere
not included in the above places)
6. Topics Covered: causes/risk factors-Does the story discuss or mention causes,
risk factors, or potential causes or risk
factors for autism?

0). 0 to 00:30
0). No
1). 00:31 to 01:00
1). Yes
2). 01:01 to 01:30
3). 01:31 to 02:00

[If 1) Yes is circled, please continue
with Question 6a. Otherwise, skip to
Question 7.]

4). 02:01 to 02:30
5). 02:31 to 03:00

6a. Topic Covered: Cause – were
causes not included, mentioned, or
main focus of story?

6). 03:01 to 03:30
7). 03:31 to 04:00
8). 04:01 to 04:30
9). 04:31 to 05:00
10). Longer than 05:01

0). Causes/risk factors were mentioned
in the story, but not the main focus
1). Causes/risk factors for autism are
the main focus of the story
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6b. Topic Covered: Cause – specific
causes
A). Genetics/Genes
0) not included
1) mentioned
2) primary focus of story
If 1) mentioned or 2) primary focus of
the story is circled, please circle one:
0) story suggests that the cause or risk
factor is unlikely
1) story suggests that the cause or risk
factor is likely
2) story suggests that not enough is known
or it is inconclusive as a cause or risk
factor
B). Brain/Neurological Irregularities
0) not included
1) mentioned
2) primary focus of story
If 1) mentioned or 2) primary focus of
the story is circled, please circle one:
0) story suggests that the cause or risk
factor is unlikely
1) story suggests that the cause or risk
factor is likely
2) story suggests that not enough is known
or it is inconclusive as a cause or risk
factor
C). Prenatal Exposure to Viruses
0) not included
1) mentioned
2) primary focus of story

0) story suggests that the cause or risk
factor is unlikely
1) story suggests that the cause or risk
factor is likely
2) story suggests that not enough is known
or it is inconclusive as a cause or risk
factor
D). Medications
0) not included
1) mentioned
2) primary focus of story
If 1) mentioned or 2) primary focus of
the story is circled, please circle one:
0) story suggests that the cause or risk
factor is unlikely
1) story suggests that the cause or risk
factor is likely
2) story suggests that not enough is known
or it is inconclusive as a cause or risk
factor
E). Vaccines
0) not included
1) mentioned
2) primary focus of story
If 1) mentioned or 2) primary focus of
the story is circled, please circle one:
0) story suggests that the cause or risk
factor is unlikely
1) story suggests that the cause or risk
factor is likely
2) story suggests that not enough is known
or it is inconclusive as a cause or risk
factor
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F). Environment
0) not included
1) mentioned
2) primary focus of story
If 1) mentioned or 2) primary focus of
the story is circled, please circle one:

[If 1) Yes is circled, please continue
with Question 7a. Otherwise, skip to
Question 8.]
7a. Topic Covered:
Statistics/Prevalence– How many
rates of autism are mentioned?
___________________

0) story suggests that the cause or risk
factor is unlikely
1) story suggests that the cause or risk
factor is likely
2) story suggests that not enough is known
or it is inconclusive as a cause or risk
factor
G). Other:
Write the cause in this space:
________________
0) not included
1) mentioned
2) primary focus of story
If 1) mentioned or 2) primary focus of
the story is circled, please circle one:
0) story suggests that the cause or risk
factor is unlikely
1) story suggests that the cause or risk
factor is likely
2) story suggests that not enough is known
or it is inconclusive as a cause or risk
factor
7. Topic Covered: Statistics/Prevalence-Does the segment present statistics or
estimates about the number of people
with autism or the prevalence of
autism?
0). No
1). Yes

7b. Topic Covered:
Statistics/Prevalence– main focus of
story or mention?
0). Statistics/prevalence of autism was
mentioned in the story, but not the main
focus.
1). Statistics/prevalence of autism was
the main focus of the story.
7c. Topic Covered:
Statistic/Prevalence– what is (are)
statistics/estimates or the prevalence
number(s) given in the story?
1. 4.5 per 10,000
2. 67 per 10,000
3. 60 per 10,000
4. 1 in 166
5. 1 in 150
6. 1 in 90 or 1 in 91
7. 1 in 110
8. 1% or 1 percent
9. other: please enter number
mentioned_______________
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7d. Topic Covered:
Statistics/Prevalence– does the story
indicate whether the rates of people
with autism or prevalence is
increasing?
0). No
1). Yes

6. Parents of or family member of a
person with autism
7. Celebrity
If a celebrity is interviewed, please list
that person’s name on the line below:
_____________________________
8. Leader or someone associated with
an advocacy organization.

8. Is autism identified as an “epidemic”?
0). No
1). Yes
9. Is autism identified as an “urgent public
health concern,” “public health
concern,” or “public health problem” or
“public health danger” or “public health
concern”?

9. Other
Please list any other identifying
information for the first person
interviewed that do(es) not fit into a
category from above:
_____________________________
10b. Interviewed: Person 2
1. Government Medical/Scientific
Expert
2. Medical Expert from a Hospital

0). No
1). Yes
10. Was anyone interviewed for the story?

3. Medical Expert from an autism
advocacy organization
4. Medical Expert from a health care
professional organization

0). No
5. Person with autism
1). Yes
10a. Interviewed: Person 1
1. Government Medical/Scientific
Expert
2. Medical Expert from a Hospital
3. Medical Expert from an autism
advocacy organization
4. Medical Expert from a health care
professional organization
5. Person with autism

6. Parents of or family member of a
person with autism
7. Celebrity
If a celebrity is interviewed, please list
that person’s name on the line below:
_____________________________
8. Leader or someone associated with
an advocacy organization.
9. Other
Please list any other identifying
information for the first person
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10c. Interviewed: Person 3
1. Government Medical/Scientific
Expert
2. Medical Expert from a Hospital
3. Medical Expert from an autism
advocacy organization
4. Medical Expert from a health care
professional organization
5. Person with autism
6. Parents of or family member of a
person with autism
7. Celebrity
If a celebrity is interviewed, please list
that person’s name on the line below:
_____________________________

interviewed that do(es) not fit into a
category from above:
_____________________________
6. Parents of or family member of a
person with autism
7. Celebrity
If a celebrity is interviewed, please list
that person’s name on the line below:
_____________________________
8. Leader or someone associated with
an advocacy organization.
9. Other
Please list any other identifying
information for the first person
interviewed that do(es) not fit into a
category from above:
_____________________________
10e. Interviewed: Person 5
1. Government Medical/Scientific
Expert
2. Medical Expert from a Hospital

8. Leader or someone associated with
an advocacy organization.
9. Other
Please list any other identifying
information for the first person
interviewed that do(es) not fit into a
category from above:
_____________________________
10d. Interviewed: Person 4
1. Government Medical/Scientific
Expert
2. Medical Expert from a Hospital
3. Medical Expert from an autism
advocacy organization
4. Medical Expert from a health care

3. Medical Expert from an autism
advocacy organization
4. Medical Expert from a health care
professional organization
5. Person with autism
6. Parents of or family member of a
person with autism
7. Celebrity
If a celebrity is interviewed, please list
that person’s name on the line below:
_____________________________
8. Leader or someone associated with
an advocacy organization.
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professional organization
5. Person with autism

11. For each person interviewed, pro-link or
anti-link (vaccines and autism)
A). Person 1
0). Anti-link

9. Other
Please list any other identifying
information for the first person
interviewed that do(es) not fit into a
category from above:
_____________________________
E). Person 5
0). Anti-link
1). Pro-link.
2). Not sure

1). Pro-link
2). Not sure
3). N/A (This person does not discuss
vaccines)
B). Person 2
0). Anti-link
1). Pro-link
2). Not sure
3). N/A (This person does not discuss
vaccines)
C). Person 3
0). Anti-link
1). Pro-link
2). Not sure
3). N/A (This person does not discuss
vaccines)
D). Person 4
0). Anti-link
1). Pro-link

3). N/A (This person does not discuss
vaccines)
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2). Not sure
3). N/A (This person does not discuss
vaccines)

